<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5786524</article-id><article-id pub-id-type="doi">10.3389/fmicb.2018.00005</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title><italic>Helicobacter pylori</italic> and Gastric Cancer: Adaptive Cellular Mechanisms Involved in Disease Progression</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>D&#x000ed;az</surname><given-names>Paula</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/418758/overview"/></contrib><contrib contrib-type="author"><name><surname>Valenzuela Valderrama</surname><given-names>Manuel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/387754/overview"/></contrib><contrib contrib-type="author"><name><surname>Bravo</surname><given-names>Jimena</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/401224/overview"/></contrib><contrib contrib-type="author"><name><surname>Quest</surname><given-names>Andrew F. G.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/224403/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Cellular Communication Laboratory, Instituto de Ciencias Biom&#x000e9;dicas, Facultad de Medicina, Universidad de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff><aff id="aff2"><sup>2</sup><institution>Advanced Center for Chronic Diseases, Facultad de Medicina, Universidad de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff><aff id="aff3"><sup>3</sup><institution>Center for Molecular Studies of the Cell, Facultad de Medicina, Universidad de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff><aff id="aff4"><sup>4</sup><institution>Instituto de Investigaci&#x000f3;n e Innovaci&#x000f3;n en Salud, Facultad de Ciencias de la Salud, Universidad Central de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Awdhesh Kalia, University of Texas MD Anderson Cancer Center, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Nagendran Tharmalingam, Alpert Medical School, Brown University, United States; Mario M. D'Elios, University of Florence, Italy</p></fn><corresp id="fn001">*Correspondence: Andrew F. G. Quest <email xlink:type="simple">aquest@med.uchile.cl</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>22</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>5</elocation-id><history><date date-type="received"><day>16</day><month>10</month><year>2017</year></date><date date-type="accepted"><day>04</day><month>1</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 D&#x000ed;az, Valenzuela Valderrama, Bravo and Quest.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>D&#x000ed;az, Valenzuela Valderrama, Bravo and Quest</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>) infection is the major risk factor associated with the development of gastric cancer. The transition from normal mucosa to non-atrophic gastritis, triggered primarily by <italic>H. pylori</italic> infection, initiates precancerous lesions which may then progress to atrophic gastritis and intestinal metaplasia. Further progression to dysplasia and gastric cancer is generally believed to be attributable to processes that no longer require the presence of <italic>H. pylori</italic>. The responses that develop upon <italic>H. pylori</italic> infection are directly mediated through the action of bacterial virulence factors, which drive the initial events associated with transformation of infected gastric cells. Besides genetic and to date poorly defined environmental factors, alterations in gastric cell stress-adaptive mechanisms due to <italic>H. pylori</italic> appear to be crucial during chronic infection and gastric disease progression. Firstly, <italic>H. pylori</italic> infection promotes gastric cell death and reduced epithelial cell turnover in the majority of infected cells, resulting in primary tissue lesions associated with an initial inflammatory response. However, in the remaining gastric cell population, adaptive responses are induced that increase cell survival and proliferation, resulting in the acquisition of potentially malignant characteristics that may lead to precancerous gastric lesions. Thus, deregulation of these intrinsic survival-related responses to <italic>H. pylori</italic> infection emerge as potential culprits in promoting disease progression. This review will highlight the most relevant cellular adaptive mechanisms triggered upon <italic>H. pylori</italic> infection, including endoplasmic reticulum stress and the unfolded protein response, autophagy, oxidative stress, and inflammation, together with a subsequent discussion on how these factors may participate in the progression of a precancerous lesion. Finally, this review will shed light on how these mechanisms may be exploited as pharmacological targets, in the perspective of opening up new therapeutic alternatives for non-invasive risk control in gastric cancer.</p></abstract><kwd-group><kwd><italic>Helicobacter pylori</italic></kwd><kwd>precancerous lesion</kwd><kwd>gastric cancer</kwd><kwd>endoplasmic reticulum stress</kwd><kwd>autophagy</kwd><kwd>inflammation</kwd><kwd>oxidative stress</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Fondo Nacional de Desarrollo Cient&#x000ed;fico y Tecnol&#x000f3;gico<named-content content-type="fundref-id">10.13039/501100002850</named-content></funding-source><award-id rid="cn001">1130250</award-id><award-id rid="cn001">1170925</award-id><award-id rid="cn001">3170140</award-id><award-id rid="cn001">1171615</award-id><award-id rid="cn001">3160384</award-id></award-group><award-group><funding-source id="cn002">Comisi&#x000f3;n Nacional de Investigaci&#x000f3;n Cient&#x000ed;fica y Tecnol&#x000f3;gica<named-content content-type="fundref-id">10.13039/501100002848</named-content></funding-source><award-id rid="cn002">15130011</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="100"/><page-count count="10"/><word-count count="8426"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Worldwide, gastric cancer (GC) is the fifth most commonly diagnosed malignancy, and the third leading cause of cancer-related deaths per year (IARC, <xref rid="B33" ref-type="bibr">2014</xref>; Lordick et al., <xref rid="B46" ref-type="bibr">2014</xref>). <italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>) is a Gram-negative, flagellated, microaerophilic bacterium that grows in close association with the lining of the stomach and the presence of this infection is identified as the major known risk factor associated with the development of GC (Suerbaum and Michetti, <xref rid="B82" ref-type="bibr">2002</xref>). Epidemiological studies report that 2&#x02013;3% of <italic>H. pylori</italic>-infected individuals eventually develop GC (Herrera and Parsonnet, <xref rid="B27" ref-type="bibr">2009</xref>).</p><p>Generally, GC is viewed as the consequence of a multifactorial process, involving the host responses, bacterial virulence, diet, and other environmental factors (Valenzuela et al., <xref rid="B85" ref-type="bibr">2015</xref>). The intestinal-type adenocarcinoma is the most frequent GC diagnosed (Hu et al., <xref rid="B29" ref-type="bibr">2012</xref>). GC development is a multistep process initiated by the transition of normal mucosa to chronic superficial gastritis (non-atrophic gastritis), triggered primarily by <italic>H. pylori</italic> infection. Gastritis may progress to atrophic gastritis, then intestinal metaplasia, and finally to dysplasia and adenocarcinoma (Correa, <xref rid="B17" ref-type="bibr">1992</xref>; Correa and Houghton, <xref rid="B18" ref-type="bibr">2007</xref>). Prospective studies have shown that antibiotic-mediated eradication of <italic>H. pylori</italic> significantly reduces the incidence of precancerous lesions and thus highlights the role of <italic>H. pylori</italic> infection in early stages of gastric carcinogenesis (Mera et al., <xref rid="B53" ref-type="bibr">2005</xref>). Indeed, removal of the bacterium with antibiotics can contribute to regression of atrophic gastritis, however this course of action is no longer effective once the disease has progressed to the stage of intestinal metaplasia (Massarrat et al., <xref rid="B49" ref-type="bibr">2012</xref>). In accordance, eradication of <italic>H. pylori</italic> in patients with metaplasia and dysplasia does not reduce the risk of GC (Chen et al., <xref rid="B14" ref-type="bibr">2016</xref>). These data suggest that the transition from atrophic gastritis to intestinal metaplasia is a crucial step in the progression towards GC and underscore the role of <italic>H. pylori</italic> in the initiation of the multistep cascade leading to precancerous lesions.</p><p>The inflammatory response that develops upon <italic>H. pylori</italic> infection is directly mediated through the action of a variety of bacterial virulence factors on host gastric epithelial cells (Peek and Crabtree, <xref rid="B66" ref-type="bibr">2006</xref>). Pathogenicity of <italic>H. pylori</italic> is attributed to bacterial factors including, but not limited to, urease, vacuolating cytotoxin A (VacA), cag pathogenicity island, cytotoxin-associated gene A (CagA), peptidoglycan outer membrane proteins (e.g., BabA, SabA, OipA), and &#x003b3;-glutamyl transpeptidase (GGT) (Polk and Peek, <xref rid="B69" ref-type="bibr">2010</xref>; Valenzuela et al., <xref rid="B86" ref-type="bibr">2013</xref>).</p><p>Besides genetic and environmental factors, alterations in gastric cell adaptive mechanisms due to <italic>H. pylori</italic> provoked stress appear to be crucial during chronic infection and gastric disorders. Initially, the <italic>H. pylori</italic>-induced effects observed during gastritis (and throughout the beginning of intestinal metaplasia) are an increase in apoptosis and a reduction in cell turnover in the majority of infected epithelial cells, thus resulting in atrophy, phenotypic changes, and the development of primary tissue lesions associated with the initial inflammatory response (Polk and Peek, <xref rid="B69" ref-type="bibr">2010</xref>). However, in the remaining gastric cell population, adaptive responses are induced that increase cell survival and proliferation, and thus the acquisition of potentially malignant characteristics that allow the progression of gastric precancerous lesions, invasion, and metastasis. As summarized in Figure <xref ref-type="fig" rid="F1">1</xref>, deregulation of intrinsic survival-related responses to <italic>H. pylori</italic> infection may emerge as potential culprits in favoring disease progression.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Schematic illustration of our current understanding of adaptive cellular mechanisms triggered upon <italic>H. pylori</italic> infection, including ER stress and the UPR, autophagy, oxidative stress, and inflammation, indicating how they may participate in precancerous lesion progression. Responses in host gastric epithelial cells located in the gastric pits triggered upon <italic>H. pylori</italic> infection are attributable to the action of bacterial virulence factors. ER stress associated with <italic>H. pylori</italic> infection, leads to an increase in BiP, suggesting that <italic>H. pylori</italic>-induction of ER stress is relevant in early stages of GC precancerous lesions. The ER stress sensor PERK may also facilitate tumor development by increasing the migratory and invasive potential of gastric cells. Unresolved ER stress results in apoptosis. ER-stress induced apoptosis is mediated by the transcription of CHOP, leading to expression of the pro-apoptotic proteins Bim and Bax. Moreover, <italic>H. pylori</italic> benefits from NF-&#x003ba;B activation and negatively regulates apoptosis via A20 deubiquitinylase activity, thereby promoting persistence of the infection. Inhibition (or activation) of autophagy, resulting in accumulation of autophagosomes within the cell at the beginning of the precancerous cascade are depicted as increasing ROS production leading to persistent oxidative stress, which in turn promotes the acquisition of characteristics, favoring invasion and metastasis. Long-term inflammation of the gastric mucosa generates significant amounts of nitric oxide (NO), which alters the transcriptional regulation in gastric cells by increasing DNA methyl transferase activity. The resulting hypermethylation of gene promoter sequences leads to epigenetic changes in gene expression. Additionally, NF-&#x003ba;B target genes include those representing polymorphisms associated with an increased risk for GC in patients, such as TNF&#x003b1;, IL-1&#x003b2;, and IL-8. Gastric cells produce ROS in response to <italic>H. pylori</italic> infection by inducing pro-oxidant activities, such as the host spermine oxidase, NADPH oxidase or generating ROS from mitochondria following activation of TLR4 signaling.</p></caption><graphic xlink:href="fmicb-09-00005-g0001"/></fig></sec><sec id="s2"><title>Endoplasmic reticulum stress and the unfolded protein response are associated with the pathogenesis of <italic>h. pylori</italic>-induced gastric tumourigenesis</title><p>Protein folding stress at the endoplasmic reticulum (ER) is involved in the pathogenesis of a variety of human diseases (Hetz, <xref rid="B28" ref-type="bibr">2012</xref>). The accumulation of unfolded and/or misfolded proteins within the ER induces ER stress, which can be resolved by an adaptive mechanism termed the unfolded protein response (UPR) (Hetz, <xref rid="B28" ref-type="bibr">2012</xref>).</p><p>Activation of ER stress was found to be significantly associated with <italic>H. pylori</italic>-positive GC (92%) (Baird et al., <xref rid="B8" ref-type="bibr">2013</xref>). In intestinal metaplasia, levels of key modulators of the UPR activated by ER stress such as HSPA5 (encoding for binding immunoglobulin protein; BiP), C/EBP-homologous protein [CHOP; positively controlled by the protein kinase R (PKR)-like ER kinase (PERK) pathway], and XBP1 (downstream of inositol-requiring enzyme-1 alpha; IRE1-&#x003b1;), were reportedly higher in <italic>H. pylori</italic>-positive subjects compared to earlier precancerous stages (i.e., non-atrophic and atrophic gastritis) (Baird et al., <xref rid="B8" ref-type="bibr">2013</xref>). This suggests that <italic>H. pylori</italic>-induction of ER stress may play a significant role in the early stages of precancerous lesion formation.</p><p>Above a certain threshold, unresolved ER stress results in apoptosis and evasion of apoptotic cell death is recognized as one of the hallmarks of cancer cells (Hanahan and Weinberg, <xref rid="B24" ref-type="bibr">2011</xref>). Thus, ER stress-induced cell death in the mucosa after <italic>H. pylori</italic> infection may favor the progression from precancerous lesions into GC. ER-stress induced apoptotic cell death is mediated by the transcription of CHOP (Tabas and Ron, <xref rid="B83" ref-type="bibr">2011</xref>). In line with this, it was reported that CHOP is transcriptionally upregulated following incubation of gastric cells with <italic>H. pylori</italic> bacterial virulence factor VacA (Akazawa et al., <xref rid="B1" ref-type="bibr">2013</xref>). Moreover, silencing of the PERK gene (EIF2AK3) attenuated VacA-mediated phosphorylation of eukaryotic initiation factor-2 alpha (eIF2&#x003b1;), expression of BH3-only protein Bim and Bax, as well as cell death induced by VacA (Akazawa et al., <xref rid="B1" ref-type="bibr">2013</xref>), indicating that ER stress may lead to apoptotic cell death during VacA-induced toxicity (Akazawa et al., <xref rid="B1" ref-type="bibr">2013</xref>). In line with this hypothesis, it has been recently reported that <italic>H. pylori</italic> benefits from NF-&#x003ba;B activation and negatively regulates apoptotic cell death via a deubiquitinylase activity, thereby promoting persistence of the infection (Lim et al., <xref rid="B45" ref-type="bibr">2017</xref>).</p><p>Furthermore, besides epithelial cells, dendritic cell alteration is also observed in the <italic>H. pylori</italic> infected gastric mucosa. Treatment of dendritic cells with purified <italic>H. pylori</italic> VacA was shown to induce translocation of cytoplasmic Bax and cytochrome c release from mitochondria and thus bring about apoptosis (Kim et al., <xref rid="B38" ref-type="bibr">2015</xref>). Indeed, suppression of ER stress appears to result in a significant inhibition of the VacA-induced apoptotic cell death in dendritic cells, suggesting that ER stress is also critical for regulation of dendritic cell apoptosis in response to VacA stimulation (Kim et al., <xref rid="B38" ref-type="bibr">2015</xref>).</p><p>The role of the ER stress sensor PERK in tumor development remains controversial (Ranganathan et al., <xref rid="B72" ref-type="bibr">2008</xref>). In agreement with the classical role of PERK in the UPR, some studies suggest that PERK activation inhibits tumor cell proliferation leading to apoptosis (Akazawa et al., <xref rid="B1" ref-type="bibr">2013</xref>; Huber et al., <xref rid="B32" ref-type="bibr">2013</xref>; Mart&#x000ed;n-P&#x000e9;rez et al., <xref rid="B48" ref-type="bibr">2014</xref>). However, other reports have shown that PERK activation facilitates tumor development by promoting tumor cell survival and enhancing angiogenesis (Atkins et al., <xref rid="B3" ref-type="bibr">2013</xref>; Mujcic et al., <xref rid="B58" ref-type="bibr">2013</xref>). Consistent with this latter role, PERK promotes tumourigenesis (Bobrovnikova-Marjon et al., <xref rid="B9" ref-type="bibr">2010</xref>) and PERK-deficient cells display a reduced ability to form solid tumors in nude mice (Spiotto et al., <xref rid="B81" ref-type="bibr">2010</xref>). More recently, a new role for PERK signaling in promoting cancer cell migration and invasion was proposed based on experiments evaluating the effects of moderate PERK activation on medulloblastoma cell migration and invasion (Jamison et al., <xref rid="B34" ref-type="bibr">2015</xref>). Overall, these observations support the idea that, besides its classical role in UPR and apoptosis, following <italic>H. pylori</italic> infection, PERK expression also promotes human gastric cell migration and invasion and thus the acquisition of an aggressive phenotype.</p></sec><sec id="s3"><title><italic>H. pylori</italic>-mediated autophagy favors the progression of gastric cancer precursor lesions</title><p>The link between ER stress and autophagy is well established, and in the context of <italic>H. pylori</italic>, it has been demonstrated that the secreted antigen HP0175 can regulate PERK, which in turn activates the transcription of ATF4 and CHOP leading to the induction of autophagy in gastric epithelial cells (Halder et al., <xref rid="B23" ref-type="bibr">2015</xref>).</p><p>Autophagy is a conserved mechanism by which the eukaryotic cell seeks to maintain cellular homeostasis; it is also induced as a survival response upon exposure to various stress stimuli, including deprivation of nutrients and infection by microbial pathogens (He and Klionsky, <xref rid="B26" ref-type="bibr">2009</xref>). Briefly, cellular components destined for degradation are sequestered within the autophagosome that fuses with the lysosome (autolysosome), where the cargo is degraded by lysosomal enzymes and recycled back to the cell (Russell et al., <xref rid="B74" ref-type="bibr">2014</xref>).</p><p>More recently, autophagy has also come to be recognized as an important intracellular defense mechanism that challenges pathogenic bacteria after their internalization by the host cell. Several types of pathogens have developed different strategies to either escape from lysosomal degradation, or control and modulate autophagy to their own benefit (Lerena et al., <xref rid="B41" ref-type="bibr">2010</xref>). In the context of <italic>H. pylori</italic> infection, Terebiznik et al. (<xref rid="B84" ref-type="bibr">2009</xref>) reported that infection of gastric epithelial cells with <italic>H. pylori</italic> for short periods (6 h) induced autophagy in a manner that was independent of the virulence factors CagA and urease, but dependent on VacA and the latter factor alone was sufficient to induce this effect (Terebiznik et al., <xref rid="B84" ref-type="bibr">2009</xref>). This suggested that autophagy acts as a mechanism by which infected cells limit toxin-induced cellular damage and thus favor cell survival. In a subsequent study, Raju et al. (<xref rid="B71" ref-type="bibr">2012</xref>) showed that prolonged exposure to VacA (24 h) disrupted the antiphagocytic pathway and defective autophagosomes were reported to accumulate within the cells (Raju et al., <xref rid="B71" ref-type="bibr">2012</xref>). Moreover, these authors showed that p62, a selective substrate for autophagy-mediated degradation, increased in gastric biopsies of patients infected with the toxic s1m1 VacA strain in comparison with those infected with a nontoxic strain (VacA <sup>s2m2</sup>). Additionally, it was reported that the effect of <italic>H. pylori</italic> in the regulation of autophagy was linked to changes in the expression of autophagy-related genes in gastric cells and macrophages (Casta&#x000f1;o-Rodr&#x000ed;guez et al., <xref rid="B11" ref-type="bibr">2015</xref>). In line with this, silencing by methylation of the microtubule-associated protein 1 light chain 3 variant 1 (MAP1LC3Av1), an important protein in the autophagy process, was observed in gastric tissue infected with <italic>H. pylori</italic> (Muhammad et al., <xref rid="B57" ref-type="bibr">2017</xref>). The available literature suggests that <italic>H. pylori</italic> modulates autophagy in the host and points toward VacA as a possible mediator; however, the reported results provide contradictory mechanisms concerning how precisely VacA might regulate this process. In addition, although the effect of virulence factor CagA in autophagy was initially discarded by Terebiznik et al. (<xref rid="B84" ref-type="bibr">2009</xref>), this factor has recently been identified as a negative regulator of autophagy in gastric mucosa of patients and AGS cells infected with a non-functional VacA strain (VacA <sup>s1m2</sup>) (Li et al., <xref rid="B43" ref-type="bibr">2017</xref>). Consequently, CagA might cause the inhibition of autophagy through the c-Met-PI3K/Akt-mTOR signaling pathway. Moreover, these authors also found higher expression of p62 in gastric biopsies of patients infected with CagA+ strains in comparison with those infected with CagA&#x02212; strains (Li et al., <xref rid="B43" ref-type="bibr">2017</xref>). Considering the latter observation, the differences found in the literature can be explained in part by the use of different cell lines and bacterial strains, however, the possibility that additional <italic>H. pylori</italic> virulence factors are likely to be involved in the regulation of autophagy in gastric cells merits further consideration. Thus, autophagy acts as a quality control system in early stages of cancer, and one may infer that the inhibition of this process at the beginning of the precancerous cascade should increase reactive oxygen species (ROS) production leading to persistent oxidative stress, which in turn causes selective pressure for the acquisition of characteristics, such as increased growth, invasion, and metastasis (Azad et al., <xref rid="B6" ref-type="bibr">2009</xref>). This would, in the case of GC, favor the progression of precursor lesions. In summary, a strong connection between <italic>H. pylori</italic> infection and autophagy is emerging that may prove relevant to GC progression.</p></sec><sec id="s4"><title><italic>H. pylori</italic>-associated inflammation</title><p>Chronic inflammation contributes to the pathogenesis of several types of cancer (Fernandes et al., <xref rid="B21" ref-type="bibr">2015</xref>) and is particularly relevant in the case of <italic>H. pylori</italic>-associated GC (Valenzuela et al., <xref rid="B85" ref-type="bibr">2015</xref>). <italic>H. pylori</italic> infection is invariably associated with gastritis; however, only a minor proportion of individuals progress through the pre-neoplastic cascade (Peek and Blaser, <xref rid="B65" ref-type="bibr">2002</xref>). Particularly, the interplay between host responses and bacterial virulence factors seems most relevant in determining the extent of inflammation and the clinical outcome (Chmiela et al., <xref rid="B16" ref-type="bibr">2017</xref>), which in turn may be favored by a permissive environment.</p><p>Beyond representing an innate response to pathogens, long-term inflammation of the gastric mucosa generates significant amounts of the diffusible molecule nitric oxide (Nam et al., <xref rid="B59" ref-type="bibr">2004</xref>), which contributes not only to the damage of nucleotide bases in host DNA, but also alters the transcriptional regulation in gastric cells by increasing DNA methyl transferase activity (Huang et al., <xref rid="B31" ref-type="bibr">2012</xref>). In doing so, epigenetic changes involving the hypermethylation of DNA sequences, particularly in tumor suppressor genes (coding and non-coding) are observed in the gastric mucosa of infected individuals (Kaise et al., <xref rid="B36" ref-type="bibr">2008</xref>; Valenzuela et al., <xref rid="B85" ref-type="bibr">2015</xref>). Accordingly, the promoter region of the tumor suppressor E-Cadherin is frequently hypermethylated in adult patients infected with <italic>H. pylori</italic> (Perri et al., <xref rid="B67" ref-type="bibr">2007</xref>). Also, the demethylating agent 5-azacytidine has been demonstrated to reduce GC incidence in the Mongolian gerbil model of infection (Niwa et al., <xref rid="B60" ref-type="bibr">2013</xref>). Additionally, chronic exposition to inflammatory cytokines is associated with deregulation of the Hedgehog/GLI signaling pathway, which is known to be involved in the maintenance of gastric physiology (Wessler et al., <xref rid="B94" ref-type="bibr">2017</xref>). In doing so, chief cells are reprogrammed toward a metaplastic phenotype, which together with the dysregulated differentiation of infiltrating gastric stem cells (e.g., bone marrow-derived cells), contributes to the so-called mosaicism in GC (Zhang et al., <xref rid="B98" ref-type="bibr">2016</xref>; Leushacke et al., <xref rid="B42" ref-type="bibr">2017</xref>; Mills and Goldenring, <xref rid="B54" ref-type="bibr">2017</xref>).</p><p>T-cell responses are essential for the generation of the inflammatory response following <italic>H. pylori</italic> infection and gastric carcinogenesis as demonstrated in animal models of infection (Kandulski et al., <xref rid="B37" ref-type="bibr">2010</xref>). Notably, <italic>H. pylori</italic> has developed mechanisms to persist in the gastric niche suppressing inflammation at sites of colonization (Every et al., <xref rid="B20" ref-type="bibr">2011</xref>). Accordingly, some virulence factors have been shown to control the extent of inflammatory responses, not only by inhibiting T-cell activation, but also by reducing phagocytosis or by promoting evasion of toll-like receptor (TLR) recognition, as well as by inducing tolerogenic effects in dendritic cells (Mej&#x000ed;as-Luque and Gerhard, <xref rid="B51" ref-type="bibr">2017</xref>). Well documented in this context are the actions of bacterial virulence factors, such as the secreted vacuolating toxin VacA and GGT, as well as the oncogenic cytotoxin CagA. Present in more virulent and carcinogenic strains, CagA is injected via the type IV secretion system encoded in the bacterial pathogenicity island (CagPAI) (Miyaji et al., <xref rid="B56" ref-type="bibr">2000</xref>; Cha et al., <xref rid="B12" ref-type="bibr">2010</xref>; Mej&#x000ed;as-Luque and Gerhard, <xref rid="B51" ref-type="bibr">2017</xref>). GGT, on the other hand, is a soluble factor that provokes oxidative stress, loss of survivin and enhanced apoptosis in gastric cells (Valenzuela et al., <xref rid="B86" ref-type="bibr">2013</xref>). In addition, <italic>H. pylori</italic> secreted peptidyl prolyl cis, trans-isomerase (HP0175) causes a gastric T-cell (Th17) response in patients with GC; leading to the production of IL-17 and IL-21, matrix degradation and the induction of pro-angiogenic pathways in response to HP0175 (Amedei et al., <xref rid="B2" ref-type="bibr">2014</xref>).</p><p>The balance between these contradictory responses seems to be determined largely by intrinsic host-specific mechanisms. In agreement with this concept, knock-out animal models have revealed the importance of some host factors in modulating inflammation. For instance, TLR9 signaling has demonstrated anti-inflammatory effects by controlling exacerbated IL-17 production (Varga et al., <xref rid="B88" ref-type="bibr">2016</xref>). Alternatively, the trefoil factor 1 suppresses <italic>H. pylori</italic>-induced inflammation by antagonizing NF-&#x003ba;B activation (Soutto et al., <xref rid="B80" ref-type="bibr">2015</xref>). The NF-&#x003ba;B protein is a master regulator of the inflammatory transcriptional response to bacterial molecules, mainly in response to injected factors, such as peptidoglycan and CagA (Sokolova and Naumann, <xref rid="B79" ref-type="bibr">2017</xref>). Importantly, certain NF-&#x003ba;B target genes such as TNF&#x003b1;, IL-1&#x003b2;, IL-2, and IL-8, present polymorphisms that are associated with increased risk for GC in patients (Valenzuela et al., <xref rid="B85" ref-type="bibr">2015</xref>; Melchiades et al., <xref rid="B52" ref-type="bibr">2017</xref>). However, it is important to consider the participation of other cell-signaling pathways in the production of inflammatory molecules. For instance, activation of the epidermal growth factor receptor (EGFR) is also associated with inflammation, DNA damage and gastric carcinogenesis (Sierra et al., <xref rid="B78" ref-type="bibr">2017</xref>).</p></sec><sec id="s5"><title><italic>H. pylori</italic> and oxidative/nitrosative stress</title><p>Oxidative stress in the gastric mucosa as a consequence of <italic>H. pylori</italic> infection is a crucial contributing factor to gastric carcinogenesis. Reportedly, infection was shown to correlate with increased damage due to oxidative stress of the gastric mucosa (Butcher et al., <xref rid="B10" ref-type="bibr">2017</xref>). Although reversible upon bacterial eradication (Pignatelli et al., <xref rid="B68" ref-type="bibr">2001</xref>), the consequences of oxidative stress are evident through observed changes in global lipid and protein expression (Baek et al., <xref rid="B7" ref-type="bibr">2004</xref>) and an increase in damaged biomolecules, such as DNA (modification of bases, telomere shortening) (Obst et al., <xref rid="B62" ref-type="bibr">2000</xref>; Lee et al., <xref rid="B40" ref-type="bibr">2016</xref>). Additionally, anti-oxidant capacity is also reduced due to decreased levels of antioxidant molecules, such a glutathione (GSH) (Shirin et al., <xref rid="B77" ref-type="bibr">2001</xref>) in the gastric mucosa of <italic>H. pylori</italic>-infected patients. The sources of reactive oxygen and nitrogen species are mainly neutrophils, macrophages and the gastric cells themselves (Valenzuela et al., <xref rid="B85" ref-type="bibr">2015</xref>). Thus, in addition to the inflammatory cells, gastric cells produce ROS in response to <italic>H. pylori</italic> infection in different ways. For instance, by inducing pro-oxidant activities, such as the host spermine oxidase enzyme, which also promotes GC risk associated with <italic>H. pylori</italic> CagA cytotoxin activity (Chaturvedi et al., <xref rid="B13" ref-type="bibr">2011</xref>), nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Cha et al., <xref rid="B12" ref-type="bibr">2010</xref>) or generating ROS from mitochondria following activation of TLR4 signaling (Yuan et al., <xref rid="B97" ref-type="bibr">2013</xref>). Also, <italic>H. pylori</italic>-neutrophil-activating protein A (NapA) activity promotes host gastric cell production of reactive oxygen intermediates (Wang et al., <xref rid="B91" ref-type="bibr">2006b</xref>). Furthermore, the secreted bacterial GGT has emerged as a relevant pathogenic factor associated with oxidative stress and inflammation (Gong et al., <xref rid="B22" ref-type="bibr">2010</xref>). GGT activity is associated with oxidation of membrane lipids using GSH as a substrate in the presence of iron (Valenzuela et al., <xref rid="B85" ref-type="bibr">2015</xref>). Nitric oxide generated by the activity of iNOS in macrophages, lymphocytes and gastric cells of the infected mucosa yields highly toxic peroxynitrite, which damages proteins and DNA by generating nitrotyrosine and DNA adducts, respectively (Sakaguchi et al., <xref rid="B75" ref-type="bibr">1999</xref>; Cherdantseva et al., <xref rid="B15" ref-type="bibr">2014</xref>; Valenzuela et al., <xref rid="B85" ref-type="bibr">2015</xref>).</p><p>On the other hand, gastric cells can escape from the oxidative stress induced by <italic>H. pylori</italic> infection by producing scavenger molecules, such as metallothioneins, which have been shown to be crucial factors in protecting against <italic>H. pylori</italic>-induced gastric erosive lesions in an animal model (Mita et al., <xref rid="B55" ref-type="bibr">2008</xref>). Other relevant antioxidant mechanisms include those involving global regulation of energy metabolism, such as the AMP-activated protein kinase (AMPK) (Zhao et al., <xref rid="B99" ref-type="bibr">2015</xref>) or the cyto-protective activity of the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) (Yanaka, <xref rid="B96" ref-type="bibr">2011</xref>). Such a harmful environment may represent major challenges for infecting bacteria, comparable even to that of acid stress. However, <italic>H. pylori</italic> is a well-adapted bacteria, able to resist oxidative stress due to mechanisms that permit the successful colonization and persistence in the gastric niche (Wang et al., <xref rid="B90" ref-type="bibr">2006a</xref>). For instance, isogenic mutants deficient in superoxide dismutase (Seyler et al., <xref rid="B76" ref-type="bibr">2001</xref>), NADPH quinone reductase (Wang and Maier, <xref rid="B92" ref-type="bibr">2004</xref>), thioredoxin (Windle et al., <xref rid="B95" ref-type="bibr">2000</xref>), and catalase (KatA) (Harris et al., <xref rid="B25" ref-type="bibr">2003</xref>) activities are sensitive to oxidative stress and are largely defective in host colonization (Seyler et al., <xref rid="B76" ref-type="bibr">2001</xref>). Furthermore, thioredoxin is an arginase chaperone and guardian against oxidative and nitrosative stress (McGee et al., <xref rid="B50" ref-type="bibr">2006</xref>). Interestingly, the bacteria itself reportedly also produces ROS (Ding et al., <xref rid="B19" ref-type="bibr">2007</xref>).</p><p>Table <xref ref-type="table" rid="T1">1</xref> summarizes the adaptive mechanisms due to <italic>H. pylori</italic> infection that could promote the acquisition of potentially malignant characteristics and favor disease progression to GC.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Summary of literature references linking <italic>H. pylori</italic> infection to induction of the UPR, ER stress, apoptosis, autophagy, inflammation, and oxidative stress.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Adaptive mechanism</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Marker(s)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Tissue/cell type</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">UPR&#x02013;ER stress</td><td valign="top" align="left" rowspan="1" colspan="1">BiP, XBP-1s, CHOP</td><td valign="top" align="left" rowspan="1" colspan="1">Human and mouse models of gastric cancer Human-derived gastric cells/<italic>H. pylori</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Baird et al., <xref rid="B8" ref-type="bibr">2013</xref></td></tr><tr style="border-top: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">ER stress&#x02013;Apoptosis</td><td valign="top" align="left" rowspan="1" colspan="1">PERK, eIF2&#x003b1;, CHOP, BH3-only protein Bim, Bax</td><td valign="top" align="left" rowspan="1" colspan="1">Human-derived gastric cells/<italic>H. pylori</italic> (VacA)</td><td valign="top" align="left" rowspan="1" colspan="1">Akazawa et al., <xref rid="B1" ref-type="bibr">2013</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Bax, cytochrome C release, CHOP, BiP</td><td valign="top" align="left" rowspan="1" colspan="1">Murine and human gastric dendritic cells/ <italic>H. pylori</italic> (VacA)</td><td valign="top" align="left" rowspan="1" colspan="1">Kim et al., <xref rid="B38" ref-type="bibr">2015</xref></td></tr><tr style="border-top: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">UPR&#x02013;ER stress&#x02013;Autophagy</td><td valign="top" align="left" rowspan="1" colspan="1">ULK1, ATG5, Beclin1, conversion LC3I to LC3II, PERK, CHOP, ATF4</td><td valign="top" align="left" rowspan="1" colspan="1">Human-derived gastric cells/<italic>H. pylori</italic> HP0175</td><td valign="top" align="left" rowspan="1" colspan="1">Halder et al., <xref rid="B23" ref-type="bibr">2015</xref></td></tr><tr style="border-top: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Apoptosis</td><td valign="top" align="left" rowspan="1" colspan="1">bcl-xl, bcl-2, survivin</td><td valign="top" align="left" rowspan="1" colspan="1">Human gastric biopsies Human-derived gastric cells/<italic>H. pylori</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Valenzuela et al., <xref rid="B87" ref-type="bibr">2010</xref></td></tr><tr style="border-top: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Autophagy</td><td valign="top" align="left" rowspan="1" colspan="1">Autophagosome detection, conversion LC3I to LC3II, GFP-LC3 detection, Atg5, Atg12</td><td valign="top" align="left" rowspan="1" colspan="1">Human-derived gastric cells/<italic>H. pylori</italic> (&#x000b1; VacA)</td><td valign="top" align="left" rowspan="1" colspan="1">Terebiznik et al., <xref rid="B84" ref-type="bibr">2009</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">p62, GFP-LC3 detection, conversion LC3I to LC3II, analysis genotypes of ATG16L1</td><td valign="top" align="left" rowspan="1" colspan="1">Human gastric tissue Peripheral blood monocytes Primary gastric cells from mice/<italic>H. pylori</italic> (&#x000b1; VacA) Human-derived gastric cells/<italic>H. pylori</italic> (&#x000b1; VacA)</td><td valign="top" align="left" rowspan="1" colspan="1">Raju et al., <xref rid="B71" ref-type="bibr">2012</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>H. pylori</italic>-related gene expression and associated polymorphisms</td><td valign="top" align="left" rowspan="1" colspan="1">Human-derived gastric cells and macrophages (THP-1) /<italic>H. pylori</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Casta&#x000f1;o-Rodr&#x000ed;guez et al., <xref rid="B11" ref-type="bibr">2015</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Methylation status/expression of Atg genes, MAP1LC3Av1 methylation silencing, map1lc3a knock-down</td><td valign="top" align="left" rowspan="1" colspan="1">Human gastric mucosa Rat gastric epithelial cells</td><td valign="top" align="left" rowspan="1" colspan="1">Muhammad et al., <xref rid="B57" ref-type="bibr">2017</xref></td></tr><tr style="border-top: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Inflammation</td><td valign="top" align="left" rowspan="1" colspan="1">iNOS, nitrotyrosine</td><td valign="top" align="left" rowspan="1" colspan="1">iNOS deficient mice/<italic>H. pylori</italic> infection</td><td valign="top" align="left" rowspan="1" colspan="1">Nam et al., <xref rid="B59" ref-type="bibr">2004</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">E-cad promoter methylation status, iNOS, NF-&#x003ba;B, nitric oxide production, DNA methyltransferase activity</td><td valign="top" align="left" rowspan="1" colspan="1">Human gastric cancer cell lines (&#x000b1; IL-1&#x003b2; or <italic>H. pylori</italic>)</td><td valign="top" align="left" rowspan="1" colspan="1">Huang et al., <xref rid="B31" ref-type="bibr">2012</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Genomic DNA and methylation-specific analysis</td><td valign="top" align="left" rowspan="1" colspan="1">Human non-cancerous corpus gastric mucosa (<italic>H. pylori</italic>)</td><td valign="top" align="left" rowspan="1" colspan="1">Kaise et al., <xref rid="B36" ref-type="bibr">2008</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Methylation analysis</td><td valign="top" align="left" rowspan="1" colspan="1">Human gastric biopsies</td><td valign="top" align="left" rowspan="1" colspan="1">Perri et al., <xref rid="B67" ref-type="bibr">2007</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">DNA methylation levels of six CpG islands; global DNA methylation levels</td><td valign="top" align="left" rowspan="1" colspan="1">Mongolian gerbil (&#x000b1; 5-aza-20-deoxycytidine/<italic>H. pylori</italic>)</td><td valign="top" align="left" rowspan="1" colspan="1">Niwa et al., <xref rid="B60" ref-type="bibr">2013</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>H. pylori</italic> colonization analysis</td><td valign="top" align="left" rowspan="1" colspan="1">Mice were infected with <italic>H. pylori</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Every et al., <xref rid="B20" ref-type="bibr">2011</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">TLR9 activation</td><td valign="top" align="left" rowspan="1" colspan="1">Tlr9/IL-17-deficient mice/<italic>H. pylori</italic> cag T4SS</td><td valign="top" align="left" rowspan="1" colspan="1">Varga et al., <xref rid="B88" ref-type="bibr">2016</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">TFF1, NF-&#x003ba;B-p65 nuclear staining, TNF&#x003b1;, IL-1&#x003b2;, chemokine [C-X-C motif] ligand 5, IL-4 receptor</td><td valign="top" align="left" rowspan="1" colspan="1">Tff1-knockout mice/<italic>H. pylori</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Soutto et al., <xref rid="B80" ref-type="bibr">2015</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">IL-2, polymorphism analysis</td><td valign="top" align="left" rowspan="1" colspan="1">Human gastric biopsies</td><td valign="top" align="left" rowspan="1" colspan="1">Melchiades et al., <xref rid="B52" ref-type="bibr">2017</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">EGFR, Cxcl1, Cxcl2, MAPK1/3, activator protein 1</td><td valign="top" align="left" rowspan="1" colspan="1">Egfr-knockout mice/<italic>H. pylori</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Sierra et al., <xref rid="B78" ref-type="bibr">2017</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>H. pylori</italic> HP0175</td><td valign="top" align="left" rowspan="1" colspan="1">Non-ulcer dyspeptic patients</td><td valign="top" align="left" rowspan="1" colspan="1">Oghalaie et al., <xref rid="B63" ref-type="bibr">2016</xref></td></tr><tr style="border-top: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Inflammation&#x02013;Apoptosis</td><td valign="top" align="left" rowspan="1" colspan="1">Ubiquitin-editing enzyme A20, NF-&#x003ba;B</td><td valign="top" align="left" rowspan="1" colspan="1">Human-derived gastric cells/<italic>H. pylori</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Lim et al., <xref rid="B45" ref-type="bibr">2017</xref></td></tr><tr style="border-top: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Oxidative stress&#x02013;Apoptosis</td><td valign="top" align="left" rowspan="1" colspan="1">Survivin</td><td valign="top" align="left" rowspan="1" colspan="1">Human-derived gastric cells/<italic>H. pylori</italic> (&#x000b1; GGT)</td><td valign="top" align="left" rowspan="1" colspan="1">Valenzuela et al., <xref rid="B86" ref-type="bibr">2013</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Inflammatory cytokines, H<sub>2</sub>O<sub>2</sub>, antioxidants, apoptosis</td><td valign="top" align="left" rowspan="1" colspan="1">Human-derived gastric cells/<italic>H. pylori</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Ding et al., <xref rid="B19" ref-type="bibr">2007</xref></td></tr><tr style="border-top: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Inflammation&#x02013;ROS</td><td valign="top" align="left" rowspan="1" colspan="1">Translocation of HSP90&#x003b2;, Rac1 activation.</td><td valign="top" align="left" rowspan="1" colspan="1">Human-derived gastric cells/<italic>H. pylori</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Cha et al., <xref rid="B12" ref-type="bibr">2010</xref></td></tr><tr style="border-top: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Oxidative stress</td><td valign="top" align="left" rowspan="1" colspan="1">iNOS, nitrotyrosine, 8-OH-dG</td><td valign="top" align="left" rowspan="1" colspan="1">Human gastric biopsies</td><td valign="top" align="left" rowspan="1" colspan="1">Pignatelli et al., <xref rid="B68" ref-type="bibr">2001</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Proteomic analysis</td><td valign="top" align="left" rowspan="1" colspan="1">Human gastric mucosa</td><td valign="top" align="left" rowspan="1" colspan="1">Baek et al., <xref rid="B7" ref-type="bibr">2004</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">ROS, GSH, DNA fragmentation</td><td valign="top" align="left" rowspan="1" colspan="1">Human-derived gastric cells/<italic>H. pylori</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Obst et al., <xref rid="B62" ref-type="bibr">2000</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">NF-&#x003ba;B, SOD, PARP-1, &#x003b3;-H2AX</td><td valign="top" align="left" rowspan="1" colspan="1">Human gastric biopsies</td><td valign="top" align="left" rowspan="1" colspan="1">Lee et al., <xref rid="B40" ref-type="bibr">2016</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Chemiluminescence, thiobarbituric acid-reactive substance-equivalent levels, GSH</td><td valign="top" align="left" rowspan="1" colspan="1">Human gastric biopsies</td><td valign="top" align="left" rowspan="1" colspan="1">Jung et al., <xref rid="B35" ref-type="bibr">2001</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">GSH</td><td valign="top" align="left" rowspan="1" colspan="1">Human gastric biopsies</td><td valign="top" align="left" rowspan="1" colspan="1">Shirin et al., <xref rid="B77" ref-type="bibr">2001</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Spermine oxidase, 8-OH-dG, apoptosis levels</td><td valign="top" align="left" rowspan="1" colspan="1">Human-derived gastric cells/<italic>H. pylori</italic> (&#x000b1; CagA)</td><td valign="top" align="left" rowspan="1" colspan="1">Chaturvedi et al., <xref rid="B13" ref-type="bibr">2011</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">TLR4, ROS</td><td valign="top" align="left" rowspan="1" colspan="1">Human gastric biopsies Human-derived gastric cells</td><td valign="top" align="left" rowspan="1" colspan="1">Yuan et al., <xref rid="B97" ref-type="bibr">2013</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>H. pylori</italic>-NapA</td><td valign="top" align="left" rowspan="1" colspan="1">C57BL/6J mice <italic>H. pylori</italic> (&#x000b1; NapA)</td><td valign="top" align="left" rowspan="1" colspan="1">Wang et al., <xref rid="B91" ref-type="bibr">2006b</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>H. pylori</italic>-GGT, H<sub>2</sub>O<sub>2</sub>, IL-8, 8-OH-dG</td><td valign="top" align="left" rowspan="1" colspan="1">Primary gastric epithelial cells Human-derived gastric cells</td><td valign="top" align="left" rowspan="1" colspan="1">Gong et al., <xref rid="B22" ref-type="bibr">2010</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Metallothionein, NF-&#x003ba;B</td><td valign="top" align="left" rowspan="1" colspan="1">Metallothionein-null mice</td><td valign="top" align="left" rowspan="1" colspan="1">Mita et al., <xref rid="B55" ref-type="bibr">2008</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">AMPK, compound 13</td><td valign="top" align="left" rowspan="1" colspan="1">Primary gastric epithelial cells Human-derived gastric cells</td><td valign="top" align="left" rowspan="1" colspan="1">Zhao et al., <xref rid="B99" ref-type="bibr">2015</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">SOD</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>H. pylori</italic>-sodB mutant C57BL/6J mice</td><td valign="top" align="left" rowspan="1" colspan="1">Seyler et al., <xref rid="B76" ref-type="bibr">2001</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">NADPH quinone reductase</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>H. pylori-</italic>MdaB protein C57BL/6J mice</td><td valign="top" align="left" rowspan="1" colspan="1">Wang and Maier, <xref rid="B92" ref-type="bibr">2004</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Thioredoxin reductase</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>H. pylori</italic>-thioredoxin</td><td valign="top" align="left" rowspan="1" colspan="1">Windle et al., <xref rid="B95" ref-type="bibr">2000</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Catalase (KatA), KatA-associated protein (KapA)</td><td valign="top" align="left" rowspan="1" colspan="1">C57/BL6 mice KatA/KapA-deficient-<italic>H. pylori</italic> mutants</td><td valign="top" align="left" rowspan="1" colspan="1">Harris et al., <xref rid="B25" ref-type="bibr">2003</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Thioredoxin 1</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>H. pylori</italic>-trxA1 mutant</td><td valign="top" align="left" rowspan="1" colspan="1">McGee et al., <xref rid="B50" ref-type="bibr">2006</xref></td></tr><tr style="border-top: thin solid #000000;"><td valign="top" align="left" rowspan="1" colspan="1">Nitrosative stress</td><td valign="top" align="left" rowspan="1" colspan="1">Peroxynitrite, iNOS, nitrotyrosine,</td><td valign="top" align="left" rowspan="1" colspan="1">Human gastric biopsies</td><td valign="top" align="left" rowspan="1" colspan="1">Sakaguchi et al., <xref rid="B75" ref-type="bibr">1999</xref></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">iNOS</td><td valign="top" align="left" rowspan="1" colspan="1">Human gastric biopsies</td><td valign="top" align="left" rowspan="1" colspan="1">Cherdantseva et al., <xref rid="B15" ref-type="bibr">2014</xref></td></tr></tbody></table><table-wrap-foot><p><italic>XBP1s, spliced X-box binding protein 1; ULK1, serine/threonine-protein kinase ULK1; ATG5, autophagy protein 5; LC3, microtubule-associated protein 1A/1B-light chain 3; ATF4, activating transcription factor 4; iNOS, nitric oxide synthase; NF-&#x003ba;B, nuclear factor kappa-light-chain-enhancer of activated B cells; TFF1, trefoil factor 1; TNF&#x003b1;, tumor necrosis factor alpha; IL, interleukin; EGFR, epidermal growth factor receptor, MAPK, mitogen-activated protein kinase; H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide; HSP90&#x003b2;, heat shock protein 90 beta; 8-OH-dG, 8-hydroxy-2'-deoxyguanosine; SOD, superoxide dismutase; PARP-1; poly [ADP-ribose] polymerase 1; NapA, neutrophil activating protein A; AMPK, AMP-activated protein kinase</italic>.</p></table-wrap-foot></table-wrap></sec><sec id="s6"><title>Discussion-potential therapeutic strategies</title><p>Understanding the regulation of adaptive chronic mechanisms by <italic>H. pylori</italic> may open up therapeutic options to prevent the progression of GC precursor lesions.</p><p>In line with this, PERK has emerged as potential therapeutic target in cancer. The compound GSK2606414 (GlaxoSmithKline&#x000ae;) was the first reported small molecular inhibitor of PERK, which is highly specific (Axten et al., <xref rid="B4" ref-type="bibr">2012</xref>). When administered orally, GSK2606414 inhibits tumor growth in a dose-dependent manner in mice with human pancreatic BxPC3 tumors (Axten et al., <xref rid="B4" ref-type="bibr">2012</xref>). Moreover, a second PERK inhibitor, GSK2656157, was developed for preclinical studies exhibiting promising results in xenograft mouse models bearing human tumors (Atkins et al., <xref rid="B3" ref-type="bibr">2013</xref>; Axten et al., <xref rid="B5" ref-type="bibr">2013</xref>). More recently, a new role for PERK signaling in promoting cancer cell migration and invasion has been proposed. Medulloblastoma cell lines treated with GSK2606414 exhibited a significant reduction in the level of phospho-eIF2&#x003b1; and concomitant suppression of cell migration and invasion (Jamison et al., <xref rid="B34" ref-type="bibr">2015</xref>). Overall, these observations support the idea that, besides its classical role in UPR and apoptosis, PERK also promotes an aggressive cellular phenotype by increasing the migratory and invasive potential. With this in mind, it is not surprising that there is considerable interest in defining whether PERK contributes to tumor progression and whether it represents a suitable therapeutic target in cancer (Pytel et al., <xref rid="B70" ref-type="bibr">2016</xref>).</p><p>On the other hand, cancer cells are thought to use autophagy as a source of energy in the unfavorable metastatic environment, and a number of clinical trials are now revealing the promising role of chloroquine, an anti-malaria drug and autophagy inhibitor, that also suppresses tumor growth and metastasis (Kimura et al., <xref rid="B39" ref-type="bibr">2013</xref>; Maes et al., <xref rid="B47" ref-type="bibr">2014</xref>). In addition, a potential role for gastrin in the regulation of autophagy has been recently proposed, opening up new avenues for the treatment of GC by targeting autophagy in combination with conventional cytostatic drugs (Rao et al., <xref rid="B73" ref-type="bibr">2017</xref>). Furthermore, the use of statins has been reported to enhance <italic>H. pylori</italic> eradication by antibiotics and to reduce <italic>H. pylori</italic>-mediated inflammation by promoting autophagy (Liao et al., <xref rid="B44" ref-type="bibr">2016</xref>); however, the mechanisms underlying these effects remain unclear.</p><p>Studies using pharmacological approaches to modulate inflammation or knock-out animal models of infection lacking cytokine receptors have highlighted the crucial importance of pro-inflammatory responses in promoting <italic>H. pylori</italic>-associated gastric carcinogenesis (Waghray et al., <xref rid="B89" ref-type="bibr">2010</xref>; Huang et al., <xref rid="B30" ref-type="bibr">2013</xref>; Oshima et al., <xref rid="B64" ref-type="bibr">2014</xref>). This may point towards the importance of protective natural dietary compounds and micronutrients in reducing inflammation and preventing carcinogenesis (Wang, <xref rid="B93" ref-type="bibr">2014</xref>; Noto and Peek, <xref rid="B61" ref-type="bibr">2015</xref>; Zitvogel et al., <xref rid="B100" ref-type="bibr">2017</xref>). Thus, natural anti-inflammatory compounds may hold considerable promise in preventing <italic>H. pylori</italic>-associated gastric pathologies (Wang, <xref rid="B93" ref-type="bibr">2014</xref>).</p><p>In summary, the mechanisms described here may be exploited as pharmacological targets, in the perspective of opening up new therapeutic alternatives for non-invasive risk control in GC. This possibility is particularly intriguing when dealing with GC, which represents the leading cause of cancer deaths in several countries (IARC, <xref rid="B33" ref-type="bibr">2014</xref>). Many highly specific inhibitors to regulate and/or control these adaptive mechanisms are already available and being evaluated in clinical trials for other cancers.</p></sec><sec id="s7"><title>Author contributions</title><p>PD, MV, and JB drafted the manuscript with support from AQ. PD drafted summary figure and table. PD, MV, JB, and AQ critically revised the article. All authors read and approved the final article.</p><sec><title>Conflict of interest statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>This work was supported CONICYT-FONDAP 15130011, Fondecyt 1130250, 1170925 (AQ); Fondecyt 3170140 (PD); Fondecyt 1171615 (MV); and Fondecyt 3160384 (JB). Dr. Gareth Owen is gratefully acknowledged for careful revision of the final manuscript.</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akazawa</surname><given-names>Y.</given-names></name><name><surname>Isomoto</surname><given-names>H.</given-names></name><name><surname>Matsushima</surname><given-names>K.</given-names></name><name><surname>Kanda</surname><given-names>T.</given-names></name><name><surname>Minami</surname><given-names>H.</given-names></name><name><surname>Yamaghchi</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Endoplasmic reticulum stress contributes to <italic>Helicobacter pylori</italic> VacA-induced apoptosis</article-title>. <source>PLoS ONE</source>
<volume>8</volume>:<fpage>e82322</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0082322</pub-id><?supplied-pmid 24349255?><pub-id pub-id-type="pmid">24349255</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amedei</surname><given-names>A.</given-names></name><name><surname>Munari</surname><given-names>F.</given-names></name><name><surname>Bella</surname><given-names>C. D.</given-names></name><name><surname>Niccolai</surname><given-names>E.</given-names></name><name><surname>Benagiano</surname><given-names>M.</given-names></name><name><surname>Bencini</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title><italic>Helicobacter pylori</italic> secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma</article-title>. <source>Intern. Emerg. Med.</source>
<volume>9</volume>, <fpage>303</fpage>&#x02013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1007/s11739-012-0867-9</pub-id><?supplied-pmid 23054412?><pub-id pub-id-type="pmid">23054412</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkins</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Minthorn</surname><given-names>E.</given-names></name><name><surname>Zhang</surname><given-names>S. Y.</given-names></name><name><surname>Figueroa</surname><given-names>D. J.</given-names></name><name><surname>Moss</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity</article-title>. <source>Cancer Res.</source>
<volume>73</volume>, <fpage>1993</fpage>&#x02013;<lpage>2002</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-3109</pub-id><?supplied-pmid 23333938?><pub-id pub-id-type="pmid">23333938</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axten</surname><given-names>J. M.</given-names></name><name><surname>Medina</surname><given-names>J. R.</given-names></name><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Shu</surname><given-names>A.</given-names></name><name><surname>Romeril</surname><given-names>S. P.</given-names></name><name><surname>Grant</surname><given-names>S. W.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-p yrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)</article-title>. <source>J. Med. Chem.</source>
<volume>55</volume>, <fpage>7193</fpage>&#x02013;<lpage>7207</lpage>. <pub-id pub-id-type="doi">10.1021/jm300713s</pub-id><pub-id pub-id-type="pmid">22827572</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axten</surname><given-names>J. M.</given-names></name><name><surname>Romeril</surname><given-names>S. P.</given-names></name><name><surname>Shu</surname><given-names>A.</given-names></name><name><surname>Ralph</surname><given-names>J.</given-names></name><name><surname>Medina</surname><given-names>J. R.</given-names></name><name><surname>Feng</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Discovery of GSK2656157: an optimized PERK inhibitor selected for preclinical development</article-title>. <source>ACS Med. Chem. Lett.</source>
<volume>4</volume>, <fpage>964</fpage>&#x02013;<lpage>968</lpage>. <pub-id pub-id-type="doi">10.1021/ml400228e</pub-id><?supplied-pmid 24900593?><pub-id pub-id-type="pmid">24900593</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azad</surname><given-names>M. B.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Gibson</surname><given-names>S. B.</given-names></name></person-group> (<year>2009</year>). <article-title>Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment</article-title>. <source>Antioxid. Redox Signal.</source>
<volume>11</volume>, <fpage>777</fpage>&#x02013;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2008.2270</pub-id><?supplied-pmid 18828708?><pub-id pub-id-type="pmid">18828708</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>H. Y.</given-names></name><name><surname>Lim</surname><given-names>J. W.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>J. M.</given-names></name><name><surname>Kim</surname><given-names>J. S.</given-names></name><name><surname>Jung</surname><given-names>H. C.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Oxidative-stress-related proteome changes in <italic>Helicobacter pylori</italic>-infected human gastric mucosa</article-title>. <source>Biochem. J.</source>
<volume>379</volume>, <fpage>291</fpage>&#x02013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1042/bj20031208</pub-id><?supplied-pmid 14711373?><pub-id pub-id-type="pmid">14711373</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baird</surname><given-names>M.</given-names></name><name><surname>Woon Ang</surname><given-names>P.</given-names></name><name><surname>Clark</surname><given-names>I.</given-names></name><name><surname>Bishop</surname><given-names>D.</given-names></name><name><surname>Oshima</surname><given-names>M.</given-names></name><name><surname>Cook</surname><given-names>M. C.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>The unfolded protein response is activated in Helicobacter-induced gastric carcinogenesis in a non-cell autonomous manner</article-title>. <source>Lab. Invest.</source>
<volume>93</volume>, <fpage>112</fpage>&#x02013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.2012.131</pub-id><?supplied-pmid 23108377?><pub-id pub-id-type="pmid">23108377</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bobrovnikova-Marjon</surname><given-names>E.</given-names></name><name><surname>Grigoriadou</surname><given-names>C.</given-names></name><name><surname>Pytel</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Ye</surname><given-names>J.</given-names></name><name><surname>Koumenis</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage</article-title>. <source>Oncogene</source>
<volume>29</volume>, <fpage>3881</fpage>&#x02013;<lpage>3895</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2010.153</pub-id><?supplied-pmid 20453876?><pub-id pub-id-type="pmid">20453876</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butcher</surname><given-names>L. D.</given-names></name><name><surname>den Hartog</surname><given-names>G.</given-names></name><name><surname>Ernst</surname><given-names>P. B.</given-names></name><name><surname>Crowe</surname><given-names>S. E.</given-names></name></person-group> (<year>2017</year>). <article-title>Oxidative stress resulting from <italic>Helicobacter pylori</italic> infection contributes to gastric carcinogenesis</article-title>. <source>Cell Mol. Gastroenterol. Hepatol.</source>
<volume>3</volume>, <fpage>316</fpage>&#x02013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmgh.2017.02.002</pub-id><?supplied-pmid 28462373?><pub-id pub-id-type="pmid">28462373</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casta&#x000f1;o-Rodr&#x000ed;guez</surname><given-names>N.</given-names></name><name><surname>Kaakoush</surname><given-names>N. O.</given-names></name><name><surname>Goh</surname><given-names>K. L.</given-names></name><name><surname>Fock</surname><given-names>K. M.</given-names></name><name><surname>Mitchell</surname><given-names>H. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Autophagy in <italic>Helicobacter pylori</italic> infection and related gastric cancer</article-title>. <source>Helicobacter</source>
<volume>20</volume>, <fpage>353</fpage>&#x02013;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1111/hel.12211</pub-id><?supplied-pmid 25664588?><pub-id pub-id-type="pmid">25664588</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>B.</given-names></name><name><surname>Lim</surname><given-names>J. W.</given-names></name><name><surname>Kim</surname><given-names>K. H.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>HSP90&#x003b2; interacts with Rac1 to activate NADPH oxidase in <italic>Helicobacter pylori</italic>-infected gastric epithelial cells</article-title>. <source>Int. J. Biochem. Cell Biol.</source>
<volume>42</volume>, <fpage>1455</fpage>&#x02013;<lpage>1461</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2010.04.015</pub-id><?supplied-pmid 20451655?><pub-id pub-id-type="pmid">20451655</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>R.</given-names></name><name><surname>Asim</surname><given-names>M.</given-names></name><name><surname>Romero-Gallo</surname><given-names>J.</given-names></name><name><surname>Barry</surname><given-names>D. P.</given-names></name><name><surname>Hoge</surname><given-names>S.</given-names></name><name><surname>de Sablet</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Spermine oxidase mediates the gastric cancer risk associated with <italic>Helicobacter pylori</italic> CagA</article-title>. <source>Gastroenterology</source>
<volume>141</volume>, <fpage>1696</fpage>&#x02013;<lpage>1708</lpage>.e2. <pub-id pub-id-type="doi">10.1053/j.gastro.2011.07.045</pub-id><?supplied-pmid 21839041?><pub-id pub-id-type="pmid">21839041</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H. N.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>Z. G.</given-names></name></person-group> (<year>2016</year>). <article-title><italic>Helicobacter pylori</italic> eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis</article-title>. <source>Gastric Cancer</source>
<volume>19</volume>, <fpage>166</fpage>&#x02013;<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1007/s10120-015-0462-7</pub-id><?supplied-pmid 25609452?><pub-id pub-id-type="pmid">25609452</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherdantseva</surname><given-names>L. A.</given-names></name><name><surname>Potapova</surname><given-names>O. V.</given-names></name><name><surname>Sharkova</surname><given-names>T. V.</given-names></name><name><surname>Belyaeva</surname><given-names>Y. Y.</given-names></name><name><surname>Shkurupiy</surname><given-names>V. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Association of <italic>Helicobacter pylori</italic> and iNOS production by macrophages and lymphocytes in the gastric mucosa in chronic gastritis</article-title>. <source>J. Immunol. Res.</source>
<volume>2014</volume>:<fpage>762514</fpage>. <pub-id pub-id-type="doi">10.1155/2014/762514</pub-id><?supplied-pmid 25309933?><pub-id pub-id-type="pmid">25309933</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chmiela</surname><given-names>M.</given-names></name><name><surname>Karwowska</surname><given-names>Z.</given-names></name><name><surname>Gonciarz</surname><given-names>W.</given-names></name><name><surname>Allushi</surname><given-names>B.</given-names></name><name><surname>Staczek</surname><given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>Host pathogen interactions in <italic>Helicobacter pylori</italic> related gastric cancer</article-title>. <source>World J. Gastroenterol.</source>
<volume>23</volume>, <fpage>1521</fpage>&#x02013;<lpage>1540</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v23.i9.1521</pub-id><?supplied-pmid 28321154?><pub-id pub-id-type="pmid">28321154</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correa</surname><given-names>P.</given-names></name></person-group> (<year>1992</year>). <article-title>Human gastric carcinogenesis: a multistep and multifactorial process&#x02013;First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention</article-title>. <source>Cancer Res.</source>
<volume>52</volume>, <fpage>6735</fpage>&#x02013;<lpage>6740</lpage>. <?supplied-pmid 1458460?><pub-id pub-id-type="pmid">1458460</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correa</surname><given-names>P.</given-names></name><name><surname>Houghton</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Carcinogenesis of <italic>Helicobacter pylori</italic></article-title>. <source>Gastroenterology</source>
<volume>133</volume>, <fpage>659</fpage>&#x02013;<lpage>672</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2007.06.026</pub-id><?supplied-pmid 17681184?><pub-id pub-id-type="pmid">17681184</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>S. Z.</given-names></name><name><surname>Minohara</surname><given-names>Y.</given-names></name><name><surname>Fan</surname><given-names>X. J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Reyes</surname><given-names>V. E.</given-names></name><name><surname>Patel</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title><italic>Helicobacter pylori</italic> infection induces oxidative stress and programmed cell death in human gastric epithelial cells</article-title>. <source>Infect. Immun.</source>
<volume>75</volume>, <fpage>4030</fpage>&#x02013;<lpage>4039</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00172-07</pub-id><?supplied-pmid 17562777?><pub-id pub-id-type="pmid">17562777</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Every</surname><given-names>A. L.</given-names></name><name><surname>Ng</surname><given-names>G. Z.</given-names></name><name><surname>Skene</surname><given-names>C. D.</given-names></name><name><surname>Harbour</surname><given-names>S. N.</given-names></name><name><surname>Walduck</surname><given-names>A. K.</given-names></name><name><surname>Mcguckin</surname><given-names>M. A.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Localized suppression of inflammation at sites of <italic>Helicobacter pylori</italic> colonization</article-title>. <source>Infect. Immun.</source>
<volume>79</volume>, <fpage>4186</fpage>&#x02013;<lpage>4192</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.05602-11</pub-id><?supplied-pmid 21807907?><pub-id pub-id-type="pmid">21807907</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>J. V.</given-names></name><name><surname>Cobucci</surname><given-names>R. N.</given-names></name><name><surname>Jatob&#x000e1;</surname><given-names>C. A.</given-names></name><name><surname>Fernandes</surname><given-names>T. A.</given-names></name><name><surname>de Azevedo</surname><given-names>J. W.</given-names></name><name><surname>de Ara&#x000fa;jo</surname><given-names>J. M.</given-names></name></person-group> (<year>2015</year>). <article-title>The role of the mediators of inflammation in cancer development</article-title>. <source>Pathol. Oncol. Res.</source>
<volume>21</volume>, <fpage>527</fpage>&#x02013;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1007/s12253-015-9913-z</pub-id><?supplied-pmid 25740073?><pub-id pub-id-type="pmid">25740073</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>M.</given-names></name><name><surname>Ling</surname><given-names>S. S.</given-names></name><name><surname>Lui</surname><given-names>S. Y.</given-names></name><name><surname>Yeoh</surname><given-names>K. G.</given-names></name><name><surname>Ho</surname><given-names>B.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>Helicobacter pylori</italic> gamma-glutamyl transpeptidase is a pathogenic factor in the development of peptic ulcer disease</article-title>. <source>Gastroenterology</source>
<volume>139</volume>, <fpage>564</fpage>&#x02013;<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2010.03.050</pub-id><?supplied-pmid 20347814?><pub-id pub-id-type="pmid">20347814</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halder</surname><given-names>P.</given-names></name><name><surname>Datta</surname><given-names>C.</given-names></name><name><surname>Kumar</surname><given-names>R.</given-names></name><name><surname>Sharma</surname><given-names>A. K.</given-names></name><name><surname>Basu</surname><given-names>J.</given-names></name><name><surname>Kundu</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>The secreted antigen, HP0175, of <italic>Helicobacter pylori</italic> links the unfolded protein response (UPR) to autophagy in gastric epithelial cells</article-title>. <source>Cell. Microbiol.</source>
<volume>17</volume>, <fpage>714</fpage>&#x02013;<lpage>729</lpage>. <pub-id pub-id-type="doi">10.1111/cmi.12396</pub-id><?supplied-pmid 25439545?><pub-id pub-id-type="pmid">25439545</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D.</given-names></name><name><surname>Weinberg</surname><given-names>R. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Hallmarks of cancer: the next generation</article-title>. <source>Cell</source>
<volume>144</volume>, <fpage>646</fpage>&#x02013;<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id><?supplied-pmid 21376230?><pub-id pub-id-type="pmid">21376230</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>A. G.</given-names></name><name><surname>Wilson</surname><given-names>J. E.</given-names></name><name><surname>Danon</surname><given-names>S. J.</given-names></name><name><surname>Dixon</surname><given-names>M. F.</given-names></name><name><surname>Donegan</surname><given-names>K.</given-names></name><name><surname>Hazell</surname><given-names>S. L.</given-names></name></person-group> (<year>2003</year>). <article-title>Catalase (KatA) and KatA-associated protein (KapA) are essential to persistent colonization in the <italic>Helicobacter pylori</italic> SS1 mouse model</article-title>. <source>Microbiology</source>
<volume>149</volume>, <fpage>665</fpage>&#x02013;<lpage>672</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.26012-0</pub-id><?supplied-pmid 12634335?><pub-id pub-id-type="pmid">12634335</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>C.</given-names></name><name><surname>Klionsky</surname><given-names>D. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Regulation mechanisms and signaling pathways of autophagy</article-title>. <source>Annu. Rev. Genet.</source>
<volume>43</volume>, <fpage>67</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-genet-102808-114910</pub-id><?supplied-pmid 19653858?><pub-id pub-id-type="pmid">19653858</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera</surname><given-names>V.</given-names></name><name><surname>Parsonnet</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title><italic>Helicobacter pylori</italic> and gastric adenocarcinoma</article-title>. <source>Clin. Microbiol. Infect.</source>
<volume>15</volume>, <fpage>971</fpage>&#x02013;<lpage>976</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-0691.2009.03031.x</pub-id><?supplied-pmid 19874380?><pub-id pub-id-type="pmid">19874380</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hetz</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>The unfolded protein response: controlling cell fate decisions under ER stress and beyond</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source>
<volume>13</volume>, <fpage>89</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3270</pub-id><?supplied-pmid 22251901?><pub-id pub-id-type="pmid">22251901</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>B.</given-names></name><name><surname>El Hajj</surname><given-names>N.</given-names></name><name><surname>Sittler</surname><given-names>S.</given-names></name><name><surname>Lammert</surname><given-names>N.</given-names></name><name><surname>Barnes</surname><given-names>R.</given-names></name><name><surname>Meloni-Ehrig</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Gastric cancer: Classification, histology and application of molecular pathology</article-title>. <source>J. Gastrointest. Oncol.</source>
<volume>3</volume>, <fpage>251</fpage>&#x02013;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.3978/j.issn.2078-6891.2012.021</pub-id><?supplied-pmid 22943016?><pub-id pub-id-type="pmid">22943016</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>F. Y.</given-names></name><name><surname>Chan</surname><given-names>A. O.</given-names></name><name><surname>Lo</surname><given-names>R. C.</given-names></name><name><surname>Rashid</surname><given-names>A.</given-names></name><name><surname>Wong</surname><given-names>D. K.</given-names></name><name><surname>Cho</surname><given-names>C. H.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Characterization of interleukin-1&#x003b2; in <italic>Helicobacter pylori</italic>-induced gastric inflammation and DNA methylation in interleukin-1 receptor type 1 knockout IL-1R1<sup>&#x02212;/&#x02212;</sup> mice</article-title>. <source>Eur. J. Cancer</source>
<volume>49</volume>, <fpage>2760</fpage>&#x02013;<lpage>2770</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejca.2013.03.031</pub-id><?supplied-pmid 23664095?><pub-id pub-id-type="pmid">23664095</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>F. Y.</given-names></name><name><surname>Chan</surname><given-names>A. O.</given-names></name><name><surname>Rashid</surname><given-names>A.</given-names></name><name><surname>Wong</surname><given-names>D. K.</given-names></name><name><surname>Cho</surname><given-names>C. H.</given-names></name><name><surname>Yuen</surname><given-names>M. F.</given-names></name></person-group> (<year>2012</year>). <article-title><italic>Helicobacter pylori</italic> induces promoter methylation of E-cadherin via interleukin-1&#x003b2; activation of nitric oxide production in gastric cancer cells</article-title>. <source>Cancer</source>
<volume>118</volume>, <fpage>4969</fpage>&#x02013;<lpage>4980</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.27519</pub-id><?supplied-pmid 22415887?><pub-id pub-id-type="pmid">22415887</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>A. L.</given-names></name><name><surname>Lebeau</surname><given-names>J.</given-names></name><name><surname>Guillaumot</surname><given-names>P.</given-names></name><name><surname>P&#x000e9;trilli</surname><given-names>V.</given-names></name><name><surname>Malek</surname><given-names>M.</given-names></name><name><surname>Chilloux</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>p58(IPK)-mediated attenuation of the proapoptotic PERK-CHOP pathway allows malignant progression upon low glucose</article-title>. <source>Mol. Cell</source>
<volume>49</volume>, <fpage>1049</fpage>&#x02013;<lpage>1059</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2013.01.009</pub-id><?supplied-pmid 23395000?><pub-id pub-id-type="pmid">23395000</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>IARC</collab></person-group> (<year>2014</year>). <source>World Cancer Report 2014.</source>
<publisher-loc>France</publisher-loc>: <publisher-name>World Health Organization</publisher-name>.</mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamison</surname><given-names>S.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>W.</given-names></name></person-group> (<year>2015</year>). <article-title>Pancreatic endoplasmic reticulum kinase activation promotes medulloblastoma cell migration and invasion through induction of vascular endothelial growth factor A</article-title>. <source>PLoS ONE</source>
<volume>10</volume>:<fpage>e0120252</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0120252</pub-id><?supplied-pmid 25794107?><pub-id pub-id-type="pmid">25794107</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>H. K.</given-names></name><name><surname>Lee</surname><given-names>K. E.</given-names></name><name><surname>Chu</surname><given-names>S. H.</given-names></name><name><surname>Yi</surname><given-names>S. Y.</given-names></name></person-group> (<year>2001</year>). <article-title>Reactive oxygen species activity, mucosal lipoperoxidation and glutathione in <italic>Helicobacter pylori</italic>-infected gastric mucosa</article-title>. <source>J. Gastroenterol. Hepatol.</source>
<volume>16</volume>, <fpage>1336</fpage>&#x02013;<lpage>1340</lpage>. <pub-id pub-id-type="doi">10.1046/j.1440-1746.2001.02647.x</pub-id><?supplied-pmid 11851829?><pub-id pub-id-type="pmid">11851829</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaise</surname><given-names>M.</given-names></name><name><surname>Yamasaki</surname><given-names>T.</given-names></name><name><surname>Yonezawa</surname><given-names>J.</given-names></name><name><surname>Miwa</surname><given-names>J.</given-names></name><name><surname>Ohta</surname><given-names>Y.</given-names></name><name><surname>Tajiri</surname><given-names>H.</given-names></name></person-group> (<year>2008</year>). <article-title>CpG island hypermethylation of tumor-suppressor genes in <italic>H. pylori-</italic>infected non-neoplastic gastric mucosa is linked with gastric cancer risk</article-title>. <source>Helicobacter</source>
<volume>13</volume>, <fpage>35</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1111/j.1523-5378.2008.00572.x</pub-id><?supplied-pmid 18205664?><pub-id pub-id-type="pmid">18205664</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kandulski</surname><given-names>A.</given-names></name><name><surname>Malfertheiner</surname><given-names>P.</given-names></name><name><surname>Wex</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Role of regulatory T-cells in <italic>H. pylori</italic>-induced gastritis and gastric cancer</article-title>. <source>Anticancer Res.</source>
<volume>30</volume>, <fpage>1093</fpage>&#x02013;<lpage>1103</lpage>. <?supplied-pmid 20530414?><pub-id pub-id-type="pmid">20530414</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. M.</given-names></name><name><surname>Kim</surname><given-names>J. S.</given-names></name><name><surname>Kim</surname><given-names>N.</given-names></name><name><surname>Ko</surname><given-names>S. H.</given-names></name><name><surname>Jeon</surname><given-names>J. I.</given-names></name><name><surname>Kim</surname><given-names>Y. J.</given-names></name></person-group> (<year>2015</year>). <article-title><italic>Helicobacter pylori</italic> vacuolating cytotoxin induces apoptosis via activation of endoplasmic reticulum stress in dendritic cells</article-title>. <source>J. Gastroenterol. Hepatol.</source>
<volume>30</volume>, <fpage>99</fpage>&#x02013;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1111/jgh.12663</pub-id><?supplied-pmid 25041690?><pub-id pub-id-type="pmid">25041690</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>T.</given-names></name><name><surname>Takabatake</surname><given-names>Y.</given-names></name><name><surname>Takahashi</surname><given-names>A.</given-names></name><name><surname>Isaka</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Chloroquine in cancer therapy: a double-edged sword of autophagy</article-title>. <source>Cancer Res.</source>
<volume>73</volume>, <fpage>3</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-2464</pub-id><?supplied-pmid 23288916?><pub-id pub-id-type="pmid">23288916</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>W. P.</given-names></name><name><surname>Hou</surname><given-names>M. C.</given-names></name><name><surname>Lan</surname><given-names>K. H.</given-names></name><name><surname>Li</surname><given-names>C. P.</given-names></name><name><surname>Chao</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>H. C.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title><italic>Helicobacter pylori</italic>-induced chronic inflammation causes telomere shortening of gastric mucosa by promoting PARP-1-mediated non-homologous end joining of DNA</article-title>. <source>Arch. Biochem. Biophys.</source>
<volume>606</volume>, <fpage>90</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2016.07.014</pub-id><?supplied-pmid 27450718?><pub-id pub-id-type="pmid">27450718</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerena</surname><given-names>M. C.</given-names></name><name><surname>V&#x000e1;zquez</surname><given-names>C. L.</given-names></name><name><surname>Colombo</surname><given-names>M. I.</given-names></name></person-group> (<year>2010</year>). <article-title>Bacterial pathogens and the autophagic response</article-title>. <source>Cell. Microbiol.</source>
<volume>12</volume>, <fpage>10</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1111/j.1462-5822.2009.01403.x</pub-id><?supplied-pmid 19888990?><pub-id pub-id-type="pmid">19888990</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leushacke</surname><given-names>M.</given-names></name><name><surname>Tan</surname><given-names>S. H.</given-names></name><name><surname>Wong</surname><given-names>A.</given-names></name><name><surname>Swathi</surname><given-names>Y.</given-names></name><name><surname>Hajamohideen</surname><given-names>A.</given-names></name><name><surname>Tan</surname><given-names>L. T.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Lgr5-expressing chief cells drive epithelial regeneration and cancer in the oxyntic stomach</article-title>. <source>Nat. Cell Biol.</source>
<volume>19</volume>, <fpage>774</fpage>&#x02013;<lpage>786</lpage>. <pub-id pub-id-type="doi">10.1038/ncb3541</pub-id><?supplied-pmid 28581476?><pub-id pub-id-type="pmid">28581476</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Tang</surname><given-names>B.</given-names></name><name><surname>Jia</surname><given-names>Y. P.</given-names></name><name><surname>Zhu</surname><given-names>P.</given-names></name><name><surname>Zhuang</surname><given-names>Y.</given-names></name><name><surname>Fang</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title><italic>Helicobacter pylori</italic> CagA protein negatively regulates autophagy and promotes inflammatory response via c-Met-PI3K/Akt-mTOR signaling pathway</article-title>. <source>Front. Cell. Infect. Microbiol.</source>
<volume>7</volume>:<fpage>417</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2017.00417</pub-id><?supplied-pmid 28983474?><pub-id pub-id-type="pmid">28983474</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>W. C.</given-names></name><name><surname>Huang</surname><given-names>M. Z.</given-names></name><name><surname>Wang</surname><given-names>M. L.</given-names></name><name><surname>Lin</surname><given-names>C. J.</given-names></name><name><surname>Lu</surname><given-names>T. L.</given-names></name><name><surname>Lo</surname><given-names>H. R.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Statin decreases <italic>Helicobacter pylori</italic> burden in macrophages by promoting autophagy</article-title>. <source>Front. Cell. Infect. Microbiol.</source>
<volume>6</volume>:<fpage>203</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2016.00203</pub-id><?supplied-pmid 28144585?><pub-id pub-id-type="pmid">28144585</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>M. C. C.</given-names></name><name><surname>Maubach</surname><given-names>G.</given-names></name><name><surname>Sokolova</surname><given-names>O.</given-names></name><name><surname>Feige</surname><given-names>M. H.</given-names></name><name><surname>Diezko</surname><given-names>R.</given-names></name><name><surname>Buchbinder</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Pathogen-induced ubiquitin-editing enzyme A20 bifunctionally shuts off NF-&#x003ba;B and caspase-8-dependent apoptotic cell death</article-title>. <source>Cell Death Differ.</source>
<volume>24</volume>, <fpage>1621</fpage>&#x02013;<lpage>1631</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2017.89</pub-id><?supplied-pmid 28574503?><pub-id pub-id-type="pmid">28574503</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lordick</surname><given-names>F.</given-names></name><name><surname>Allum</surname><given-names>W.</given-names></name><name><surname>Carneiro</surname><given-names>F.</given-names></name><name><surname>Mitry</surname><given-names>E.</given-names></name><name><surname>Tabernero</surname><given-names>J.</given-names></name><name><surname>Tan</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Unmet needs and challenges in gastric cancer: the way forward</article-title>. <source>Cancer Treat. Rev.</source>
<volume>40</volume>, <fpage>692</fpage>&#x02013;<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1016/j.ctrv.2014.03.002</pub-id><?supplied-pmid 24656602?><pub-id pub-id-type="pmid">24656602</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>H.</given-names></name><name><surname>Kuchnio</surname><given-names>A.</given-names></name><name><surname>Peric</surname><given-names>A.</given-names></name><name><surname>Moens</surname><given-names>S.</given-names></name><name><surname>Nys</surname><given-names>K.</given-names></name><name><surname>De Bock</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Tumor vessel normalization by chloroquine independent of autophagy</article-title>. <source>Cancer Cell</source>
<volume>26</volume>, <fpage>190</fpage>&#x02013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2014.06.025</pub-id><?supplied-pmid 25117709?><pub-id pub-id-type="pmid">25117709</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;n-P&#x000e9;rez</surname><given-names>R.</given-names></name><name><surname>Palacios</surname><given-names>C.</given-names></name><name><surname>Yerbes</surname><given-names>R.</given-names></name><name><surname>Cano-Gonz&#x000e1;lez</surname><given-names>A.</given-names></name><name><surname>Iglesias-Serret</surname><given-names>D.</given-names></name><name><surname>Gil</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Activated ERBB2/HER2 licenses sensitivity to apoptosis upon endoplasmic reticulum stress through a PERK-dependent pathway</article-title>. <source>Cancer Res.</source>
<volume>74</volume>, <fpage>1766</fpage>&#x02013;<lpage>1777</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-1747</pub-id><?supplied-pmid 24453000?><pub-id pub-id-type="pmid">24453000</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massarrat</surname><given-names>S.</given-names></name><name><surname>Haj-Sheykholeslami</surname><given-names>A.</given-names></name><name><surname>Mohamadkhani</surname><given-names>A.</given-names></name><name><surname>Zendehdel</surname><given-names>N.</given-names></name><name><surname>Rakhshani</surname><given-names>N.</given-names></name><name><surname>Stolte</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Precancerous conditions after <italic>H. pylori</italic> eradication: a randomized double blind study in first degree relatives of gastric cancer patients</article-title>. <source>Arch. Iran. Med.</source>
<volume>15</volume>, <fpage>664</fpage>&#x02013;<lpage>669</lpage>. <?supplied-pmid 23102241?><pub-id pub-id-type="pmid">23102241</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGee</surname><given-names>D. J.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Viator</surname><given-names>R. J.</given-names></name><name><surname>Bolland</surname><given-names>J. R.</given-names></name><name><surname>Ruiz</surname><given-names>J.</given-names></name><name><surname>Spadafora</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title><italic>Helicobacter pylori</italic> thioredoxin is an arginase chaperone and guardian against oxidative and nitrosative stresses</article-title>. <source>J. Biol. Chem.</source>
<volume>281</volume>, <fpage>3290</fpage>&#x02013;<lpage>3296</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M506139200</pub-id><?supplied-pmid 16354674?><pub-id pub-id-type="pmid">16354674</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mej&#x000ed;as-Luque</surname><given-names>R.</given-names></name><name><surname>Gerhard</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Immune evasion strategies and persistence of <italic>Helicobacter pylori</italic></article-title>. <source>Curr. Top. Microbiol. Immunol.</source>
<volume>400</volume>, <fpage>53</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-50520-6_3</pub-id><?supplied-pmid 28124149?><pub-id pub-id-type="pmid">28124149</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melchiades</surname><given-names>J. L.</given-names></name><name><surname>Zabaglia</surname><given-names>L. M.</given-names></name><name><surname>Sallas</surname><given-names>M. L.</given-names></name><name><surname>Orcini</surname><given-names>W. A.</given-names></name><name><surname>Chen</surname><given-names>E.</given-names></name><name><surname>Smith</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Polymorphisms and haplotypes of the interleukin 2 gene are associated with an increased risk of gastric cancer. The possible involvement of Helicobacter pylori</article-title>. <source>Cytokine</source>
<volume>96</volume>, <fpage>203</fpage>&#x02013;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1016/j.cyto.2017.04.020</pub-id><?supplied-pmid 28458166?><pub-id pub-id-type="pmid">28458166</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mera</surname><given-names>R.</given-names></name><name><surname>Fontham</surname><given-names>E. T.</given-names></name><name><surname>Bravo</surname><given-names>L. E.</given-names></name><name><surname>Bravo</surname><given-names>J. C.</given-names></name><name><surname>Piazuelo</surname><given-names>M. B.</given-names></name><name><surname>Camargo</surname><given-names>M. C.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>Long term follow up of patients treated for <italic>Helicobacter pylori</italic> infection</article-title>. <source>Gut</source>
<volume>54</volume>, <fpage>1536</fpage>&#x02013;<lpage>1540</lpage>. <pub-id pub-id-type="doi">10.1136/gut.2005.072009</pub-id><?supplied-pmid 15985559?><pub-id pub-id-type="pmid">15985559</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>J. C.</given-names></name><name><surname>Goldenring</surname><given-names>J. R.</given-names></name></person-group> (<year>2017</year>). <article-title>Metaplasia in the stomach arises from gastric chief cells</article-title>. <source>Cell Mol. Gastroenterol. Hepatol.</source>
<volume>4</volume>, <fpage>85</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmgh.2017.03.006</pub-id><?supplied-pmid 28560292?><pub-id pub-id-type="pmid">28560292</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mita</surname><given-names>M.</given-names></name><name><surname>Satoh</surname><given-names>M.</given-names></name><name><surname>Shimada</surname><given-names>A.</given-names></name><name><surname>Okajima</surname><given-names>M.</given-names></name><name><surname>Azuma</surname><given-names>S.</given-names></name><name><surname>Suzuki</surname><given-names>J. S.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Metallothionein is a crucial protective factor against <italic>Helicobacter pylori</italic>-induced gastric erosive lesions in a mouse model</article-title>. <source>Am. J. Physiol. Gastrointest. Liver Physiol.</source>
<volume>294</volume>, <fpage>G877</fpage>&#x02013;<lpage>884</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00251.2007</pub-id><?supplied-pmid 18239062?><pub-id pub-id-type="pmid">18239062</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyaji</surname><given-names>H.</given-names></name><name><surname>Azuma</surname><given-names>T.</given-names></name><name><surname>Ito</surname><given-names>S.</given-names></name><name><surname>Abe</surname><given-names>Y.</given-names></name><name><surname>Gejyo</surname><given-names>F.</given-names></name><name><surname>Hashimoto</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title><italic>Helicobacter pylori</italic> infection occurs via close contact with infected individuals in early childhood</article-title>. <source>J. Gastroenterol. Hepatol.</source>
<volume>15</volume>, <fpage>257</fpage>&#x02013;<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1046/j.1440-1746.2000.02070.x</pub-id><?supplied-pmid 10764025?><pub-id pub-id-type="pmid">10764025</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muhammad</surname><given-names>J. S.</given-names></name><name><surname>Nanjo</surname><given-names>S.</given-names></name><name><surname>Ando</surname><given-names>T.</given-names></name><name><surname>Yamashita</surname><given-names>S.</given-names></name><name><surname>Maekita</surname><given-names>T.</given-names></name><name><surname>Ushijima</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Autophagy impairment by <italic>Helicobacter pylori</italic>-induced methylation silencing of MAP1LC3Av1 promotes gastric carcinogenesis</article-title>. <source>Int. J. Cancer</source>
<volume>140</volume>, <fpage>2272</fpage>&#x02013;<lpage>2283</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.30657</pub-id><?supplied-pmid 28214334?><pub-id pub-id-type="pmid">28214334</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mujcic</surname><given-names>H.</given-names></name><name><surname>Nagelkerke</surname><given-names>A.</given-names></name><name><surname>Rouschop</surname><given-names>K. M.</given-names></name><name><surname>Chung</surname><given-names>S.</given-names></name><name><surname>Chaudary</surname><given-names>N.</given-names></name><name><surname>Span</surname><given-names>P. N.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Hypoxic activation of the PERK/eIF2&#x003b1; arm of the unfolded protein response promotes metastasis through induction of LAMP3</article-title>. <source>Clin. Cancer Res.</source>
<volume>19</volume>, <fpage>6126</fpage>&#x02013;<lpage>6137</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-13-0526</pub-id><?supplied-pmid 24045183?><pub-id pub-id-type="pmid">24045183</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>K. T.</given-names></name><name><surname>Oh</surname><given-names>S. Y.</given-names></name><name><surname>Ahn</surname><given-names>B.</given-names></name><name><surname>Kim</surname><given-names>Y. B.</given-names></name><name><surname>Jang</surname><given-names>D. D.</given-names></name><name><surname>Yang</surname><given-names>K. H.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Decreased <italic>Helicobacter pylori</italic> associated gastric carcinogenesis in mice lacking inducible nitric oxide synthase</article-title>. <source>Gut</source>
<volume>53</volume>, <fpage>1250</fpage>&#x02013;<lpage>1255</lpage>. <pub-id pub-id-type="doi">10.1136/gut.2003.030684</pub-id><?supplied-pmid 15306579?><pub-id pub-id-type="pmid">15306579</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niwa</surname><given-names>T.</given-names></name><name><surname>Toyoda</surname><given-names>T.</given-names></name><name><surname>Tsukamoto</surname><given-names>T.</given-names></name><name><surname>Mori</surname><given-names>A.</given-names></name><name><surname>Tatematsu</surname><given-names>M.</given-names></name><name><surname>Ushijima</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Prevention of <italic>Helicobacter pylori</italic>-induced gastric cancers in gerbils by a DNA demethylating agent</article-title>. <source>Cancer Prev. Res. (Phila)</source>
<volume>6</volume>, <fpage>263</fpage>&#x02013;<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-12-0369</pub-id><?supplied-pmid 23559452?><pub-id pub-id-type="pmid">23559452</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noto</surname><given-names>J. M.</given-names></name><name><surname>Peek</surname><given-names>R. M.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2015</year>). <article-title>Micronutrients: a double-edged sword in microbial-induced gastric carcinogenesis</article-title>. <source>Trends Cancer</source>
<volume>1</volume>, <fpage>136</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/j.trecan.2015.07.002</pub-id><?supplied-pmid 26623443?><pub-id pub-id-type="pmid">26623443</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obst</surname><given-names>B.</given-names></name><name><surname>Wagner</surname><given-names>S.</given-names></name><name><surname>Sewing</surname><given-names>K. F.</given-names></name><name><surname>Beil</surname><given-names>W.</given-names></name></person-group> (<year>2000</year>). <article-title><italic>Helicobacter pylori</italic> causes DNA damage in gastric epithelial cells</article-title>. <source>Carcinogenesis</source>
<volume>21</volume>, <fpage>1111</fpage>&#x02013;<lpage>1115</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/21.6.1111</pub-id><?supplied-pmid 10836997?><pub-id pub-id-type="pmid">10836997</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oghalaie</surname><given-names>A.</given-names></name><name><surname>Saberi</surname><given-names>S.</given-names></name><name><surname>Esmaeili</surname><given-names>M.</given-names></name><name><surname>Ebrahimzadeh</surname><given-names>F.</given-names></name><name><surname>Barkhordari</surname><given-names>F.</given-names></name><name><surname>Ghamarian</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title><italic>Helicobacter pylori</italic> peptidyl prolyl isomerase expression is associated with the severity of gastritis</article-title>. <source>J. Gastrointest. Cancer</source>
<volume>47</volume>, <fpage>375</fpage>&#x02013;<lpage>380</lpage>. <pub-id pub-id-type="doi">10.1007/s12029-016-9849-x</pub-id><?supplied-pmid 27370181?><pub-id pub-id-type="pmid">27370181</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oshima</surname><given-names>H.</given-names></name><name><surname>Ishikawa</surname><given-names>T.</given-names></name><name><surname>Yoshida</surname><given-names>G. J.</given-names></name><name><surname>Naoi</surname><given-names>K.</given-names></name><name><surname>Maeda</surname><given-names>Y.</given-names></name><name><surname>Naka</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>TNF-&#x003b1;/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells</article-title>. <source>Oncogene</source>
<volume>33</volume>, <fpage>3820</fpage>&#x02013;<lpage>3829</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2013.356</pub-id><?supplied-pmid 23975421?><pub-id pub-id-type="pmid">23975421</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peek</surname><given-names>R. M.</given-names><suffix>Jr.</suffix></name><name><surname>Blaser</surname><given-names>M. J.</given-names></name></person-group> (<year>2002</year>). <article-title><italic>Helicobacter pylori</italic> and gastrointestinal tract adenocarcinomas</article-title>. <source>Nat. Rev. Cancer</source>
<volume>2</volume>, <fpage>28</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1038/nrc703</pub-id><?supplied-pmid 11902583?><pub-id pub-id-type="pmid">11902583</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peek</surname><given-names>R. M.</given-names><suffix>Jr.</suffix></name><name><surname>Crabtree</surname><given-names>J. E.</given-names></name></person-group> (<year>2006</year>). <article-title>Helicobacter infection and gastric neoplasia</article-title>. <source>J. Pathol.</source>
<volume>208</volume>, <fpage>233</fpage>&#x02013;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1002/path.1868</pub-id><?supplied-pmid 16362989?><pub-id pub-id-type="pmid">16362989</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perri</surname><given-names>F.</given-names></name><name><surname>Cotugno</surname><given-names>R.</given-names></name><name><surname>Piepoli</surname><given-names>A.</given-names></name><name><surname>Merla</surname><given-names>A.</given-names></name><name><surname>Quitadamo</surname><given-names>M.</given-names></name><name><surname>Gentile</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Aberrant DNA methylation in non-neoplastic gastric mucosa of <italic>H. pylori</italic> infected patients and effect of eradication</article-title>. <source>Am. J. Gastroenterol.</source>
<volume>102</volume>, <fpage>1361</fpage>&#x02013;<lpage>1371</lpage>. <pub-id pub-id-type="doi">10.1111/j.1572-0241.2007.01284.x</pub-id><?supplied-pmid 17509026?><pub-id pub-id-type="pmid">17509026</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pignatelli</surname><given-names>B.</given-names></name><name><surname>Bancel</surname><given-names>B.</given-names></name><name><surname>Plummer</surname><given-names>M.</given-names></name><name><surname>Toyokuni</surname><given-names>S.</given-names></name><name><surname>Patricot</surname><given-names>L. M.</given-names></name><name><surname>Ohshima</surname><given-names>H.</given-names></name></person-group> (<year>2001</year>). <article-title><italic>Helicobacter pylori</italic> eradication attenuates oxidative stress in human gastric mucosa</article-title>. <source>Am. J. Gastroenterol.</source>
<volume>96</volume>, <fpage>1758</fpage>&#x02013;<lpage>1766</lpage>. <pub-id pub-id-type="doi">10.1111/j.1572-0241.2001.03869.x</pub-id><?supplied-pmid 11419826?><pub-id pub-id-type="pmid">11419826</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polk</surname><given-names>D. B.</given-names></name><name><surname>Peek</surname><given-names>R. M.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2010</year>). <article-title><italic>Helicobacter pylori</italic>: gastric cancer and beyond</article-title>. <source>Nat. Rev. Cancer</source>
<volume>10</volume>, <fpage>403</fpage>&#x02013;<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1038/nrc2857</pub-id><?supplied-pmid 20495574?><pub-id pub-id-type="pmid">20495574</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pytel</surname><given-names>D.</given-names></name><name><surname>Majsterek</surname><given-names>I.</given-names></name><name><surname>Diehl</surname><given-names>J. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Tumor progression and the different faces of the PERK kinase</article-title>. <source>Oncogene</source>
<volume>35</volume>, <fpage>1207</fpage>&#x02013;<lpage>1215</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2015.178</pub-id><?supplied-pmid 26028033?><pub-id pub-id-type="pmid">26028033</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raju</surname><given-names>D.</given-names></name><name><surname>Hussey</surname><given-names>S.</given-names></name><name><surname>Ang</surname><given-names>M.</given-names></name><name><surname>Terebiznik</surname><given-names>M. R.</given-names></name><name><surname>Sibony</surname><given-names>M.</given-names></name><name><surname>Galindo-Mata</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote <italic>Helicobacter pylori</italic> infection in humans</article-title>. <source>Gastroenterology</source>
<volume>142</volume>, <fpage>1160</fpage>&#x02013;<lpage>1171</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2012.01.043</pub-id><?supplied-pmid 22333951?><pub-id pub-id-type="pmid">22333951</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranganathan</surname><given-names>A. C.</given-names></name><name><surname>Ojha</surname><given-names>S.</given-names></name><name><surname>Kourtidis</surname><given-names>A.</given-names></name><name><surname>Conklin</surname><given-names>D. S.</given-names></name><name><surname>Aguirre-Ghiso</surname><given-names>J. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Dual function of pancreatic endoplasmic reticulum kinase in tumor cell growth arrest and survival</article-title>. <source>Cancer Res.</source>
<volume>68</volume>, <fpage>3260</fpage>&#x02013;<lpage>3268</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-6215</pub-id><?supplied-pmid 18451152?><pub-id pub-id-type="pmid">18451152</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>S. V.</given-names></name><name><surname>Solum</surname><given-names>G.</given-names></name><name><surname>Niederdorfer</surname><given-names>B.</given-names></name><name><surname>N&#x000f8;rsett</surname><given-names>K. G.</given-names></name><name><surname>Bj&#x000f8;rk&#x000f8;y</surname><given-names>G.</given-names></name><name><surname>Thommesen</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>Gastrin activates autophagy and increases migration and survival of gastric adenocarcinoma cells</article-title>. <source>BMC Cancer</source>
<volume>17</volume>:<fpage>68</fpage>. <pub-id pub-id-type="doi">10.1186/s12885-017-3055-5</pub-id><?supplied-pmid 28109268?><pub-id pub-id-type="pmid">28109268</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>R. C.</given-names></name><name><surname>Yuan</surname><given-names>H. X.</given-names></name><name><surname>Guan</surname><given-names>K. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Autophagy regulation by nutrient signaling</article-title>. <source>Cell Res.</source>
<volume>24</volume>, <fpage>42</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2013.166</pub-id><?supplied-pmid 24343578?><pub-id pub-id-type="pmid">24343578</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>A. A.</given-names></name><name><surname>Miura</surname><given-names>S.</given-names></name><name><surname>Takeuchi</surname><given-names>T.</given-names></name><name><surname>Hokari</surname><given-names>R.</given-names></name><name><surname>Mizumori</surname><given-names>M.</given-names></name><name><surname>Yoshida</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>1999</year>). <article-title>Increased expression of inducible nitric oxide synthase and peroxynitrite in <italic>Helicobacter pylori</italic> gastric ulcer</article-title>. <source>Free Radic. Biol. Med.</source>
<volume>27</volume>, <fpage>781</fpage>&#x02013;<lpage>789</lpage>. <pub-id pub-id-type="doi">10.1016/S0891-5849(99)00124-0</pub-id><?supplied-pmid 10515582?><pub-id pub-id-type="pmid">10515582</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seyler</surname><given-names>R. W.</given-names><suffix>Jr.</suffix></name><name><surname>Olson</surname><given-names>J. W.</given-names></name><name><surname>Maier</surname><given-names>R. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Superoxide dismutase-deficient mutants of <italic>Helicobacter pylori</italic> are hypersensitive to oxidative stress and defective in host colonization</article-title>. <source>Infect. Immun.</source>
<volume>69</volume>, <fpage>4034</fpage>&#x02013;<lpage>4040</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.69.6.4034-4040.2001</pub-id><?supplied-pmid 11349073?><pub-id pub-id-type="pmid">11349073</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirin</surname><given-names>H.</given-names></name><name><surname>Pinto</surname><given-names>J. T.</given-names></name><name><surname>Liu</surname><given-names>L. U.</given-names></name><name><surname>Merzianu</surname><given-names>M.</given-names></name><name><surname>Sordillo</surname><given-names>E. M.</given-names></name><name><surname>Moss</surname><given-names>S. F.</given-names></name></person-group> (<year>2001</year>). <article-title><italic>Helicobacter pylori</italic> decreases gastric mucosal glutathione</article-title>. <source>Cancer Lett.</source>
<volume>164</volume>, <fpage>127</fpage>&#x02013;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1016/S0304-3835(01)00383-4</pub-id><?supplied-pmid 11179826?><pub-id pub-id-type="pmid">11179826</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sierra</surname><given-names>J. C.</given-names></name><name><surname>Asim</surname><given-names>M.</given-names></name><name><surname>Verriere</surname><given-names>T. G.</given-names></name><name><surname>Piazuelo</surname><given-names>M. B.</given-names></name><name><surname>Suarez</surname><given-names>G.</given-names></name><name><surname>Romero-Gallo</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Epidermal growth factor receptor inhibition downregulates <italic>Helicobacter pylori</italic>-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis</article-title>. <source>Gut.</source> [Epub ahead of print]. <pub-id pub-id-type="doi">10.1136/gutjnl-2016-312888</pub-id><?supplied-pmid 28473630?><pub-id pub-id-type="pmid">28473630</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokolova</surname><given-names>O.</given-names></name><name><surname>Naumann</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>NF-&#x003ba;B signaling in gastric cancer</article-title>. <source>Toxins (Basel)</source>
<volume>9</volume>:<fpage>E119</fpage>. <pub-id pub-id-type="doi">10.3390/toxins9040119</pub-id><?supplied-pmid 28350359?><pub-id pub-id-type="pmid">28350359</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soutto</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Katsha</surname><given-names>A. M.</given-names></name><name><surname>Romero-Gallo</surname><given-names>J.</given-names></name><name><surname>Krishna</surname><given-names>U. S.</given-names></name><name><surname>Piazuelo</surname><given-names>M. B.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Trefoil factor 1 expression suppresses <italic>Helicobacter pylori</italic>-induced inflammation in gastric carcinogenesis</article-title>. <source>Cancer</source>
<volume>121</volume>, <fpage>4348</fpage>&#x02013;<lpage>4358</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.29644</pub-id><?supplied-pmid 26372254?><pub-id pub-id-type="pmid">26372254</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiotto</surname><given-names>M. T.</given-names></name><name><surname>Banh</surname><given-names>A.</given-names></name><name><surname>Papandreou</surname><given-names>I.</given-names></name><name><surname>Cao</surname><given-names>H.</given-names></name><name><surname>Galvez</surname><given-names>M. G.</given-names></name><name><surname>Gurtner</surname><given-names>G. C.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Imaging the unfolded protein response in primary tumors reveals microenvironments with metabolic variations that predict tumor growth</article-title>. <source>Cancer Res.</source>
<volume>70</volume>, <fpage>78</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-2747</pub-id><?supplied-pmid 20028872?><pub-id pub-id-type="pmid">20028872</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suerbaum</surname><given-names>S.</given-names></name><name><surname>Michetti</surname><given-names>P.</given-names></name></person-group> (<year>2002</year>). <article-title><italic>Helicobacter pylori</italic> infection</article-title>. <source>N. Engl. J. Med.</source>
<volume>347</volume>, <fpage>1175</fpage>&#x02013;<lpage>1186</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra020542</pub-id><?supplied-pmid 12374879?><pub-id pub-id-type="pmid">12374879</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabas</surname><given-names>I.</given-names></name><name><surname>Ron</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress</article-title>. <source>Nat. Cell Biol.</source>
<volume>13</volume>, <fpage>184</fpage>&#x02013;<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1038/ncb0311-184</pub-id><?supplied-pmid 21364565?><pub-id pub-id-type="pmid">21364565</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terebiznik</surname><given-names>M. R.</given-names></name><name><surname>Raju</surname><given-names>D.</given-names></name><name><surname>V&#x000e1;zquez</surname><given-names>C. L.</given-names></name><name><surname>Torbricki</surname><given-names>K.</given-names></name><name><surname>Kulkarni</surname><given-names>R.</given-names></name><name><surname>Blanke</surname><given-names>S. R.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Effect of <italic>Helicobacter pylori</italic>'s vacuolating cytotoxin on the autophagy pathway in gastric epithelial cells</article-title>. <source>Autophagy</source>
<volume>5</volume>, <fpage>370</fpage>&#x02013;<lpage>379</lpage>. <pub-id pub-id-type="doi">10.4161/auto.5.3.7663</pub-id><?supplied-pmid 19164948?><pub-id pub-id-type="pmid">19164948</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valenzuela</surname><given-names>M. A.</given-names></name><name><surname>Canales</surname><given-names>J.</given-names></name><name><surname>Corval&#x000e1;n</surname><given-names>A. H.</given-names></name><name><surname>Quest</surname><given-names>A. F.</given-names></name></person-group> (<year>2015</year>). <article-title><italic>Helicobacter pylori</italic>-induced inflammation and epigenetic changes during gastric carcinogenesis</article-title>. <source>World J. Gastroenterol.</source>
<volume>21</volume>, <fpage>12742</fpage>&#x02013;<lpage>12756</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v21.i45.12742</pub-id><?supplied-pmid 26668499?><pub-id pub-id-type="pmid">26668499</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valenzuela</surname><given-names>M.</given-names></name><name><surname>Bravo</surname><given-names>D.</given-names></name><name><surname>Canales</surname><given-names>J.</given-names></name><name><surname>Sanhueza</surname><given-names>C.</given-names></name><name><surname>D&#x000ed;az</surname><given-names>N.</given-names></name><name><surname>Almarza</surname><given-names>O.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title><italic>Helicobacter pylori</italic>-induced loss of survivin and gastric cell viability is attributable to secreted bacterial gamma-glutamyl transpeptidase activity</article-title>. <source>J. Infect. Dis.</source>
<volume>208</volume>, <fpage>1131</fpage>&#x02013;<lpage>1141</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jit286</pub-id><?supplied-pmid 23847060?><pub-id pub-id-type="pmid">23847060</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valenzuela</surname><given-names>M.</given-names></name><name><surname>Perez-Perez</surname><given-names>G.</given-names></name><name><surname>Corvalan</surname><given-names>A. H.</given-names></name><name><surname>Carrasco</surname><given-names>G.</given-names></name><name><surname>Urra</surname><given-names>H.</given-names></name><name><surname>Bravo</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title><italic>Helicobacter pylori</italic>-induced loss of the inhibitor-of-apoptosis protein survivin is linked to gastritis and death of human gastric cells</article-title>. <source>J. Infect. Dis.</source>
<volume>202</volume>, <fpage>1021</fpage>&#x02013;<lpage>1030</lpage>. <pub-id pub-id-type="doi">10.1086/656143</pub-id><?supplied-pmid 20735270?><pub-id pub-id-type="pmid">20735270</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varga</surname><given-names>M. G.</given-names></name><name><surname>Piazuelo</surname><given-names>M. B.</given-names></name><name><surname>Romero-Gallo</surname><given-names>J.</given-names></name><name><surname>Delgado</surname><given-names>A. G.</given-names></name><name><surname>Suarez</surname><given-names>G.</given-names></name><name><surname>Whitaker</surname><given-names>M. E.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>TLR9 activation suppresses inflammation in response to <italic>Helicobacter pylori</italic> infection</article-title>. <source>Am. J. Physiol. Gastrointest. Liver Physiol.</source>
<volume>311</volume>, <fpage>G852</fpage>&#x02013;<lpage>G858</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00175.2016</pub-id><?supplied-pmid 27758771?><pub-id pub-id-type="pmid">27758771</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waghray</surname><given-names>M.</given-names></name><name><surname>Zavros</surname><given-names>Y.</given-names></name><name><surname>Saqui-Salces</surname><given-names>M.</given-names></name><name><surname>El-Zaatari</surname><given-names>M.</given-names></name><name><surname>Alamelumangapuram</surname><given-names>C. B.</given-names></name><name><surname>Todisco</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Interleukin-1&#x003b2; promotes gastric atrophy through suppression of Sonic Hedgehog</article-title>. <source>Gastroenterology</source>
<volume>138</volume>, <fpage>562</fpage>&#x02013;<lpage>572</lpage>.e2. <pub-id pub-id-type="doi">10.1053/j.gastro.2009.10.043</pub-id><?supplied-pmid 19883649?><pub-id pub-id-type="pmid">19883649</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Alamuri</surname><given-names>P.</given-names></name><name><surname>Maier</surname><given-names>R. J.</given-names></name></person-group> (<year>2006a</year>). <article-title>The diverse antioxidant systems of <italic>Helicobacter pylori</italic></article-title>. <source>Mol. Microbiol.</source>
<volume>61</volume>, <fpage>847</fpage>&#x02013;<lpage>860</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05302.x</pub-id><?supplied-pmid 16879643?><pub-id pub-id-type="pmid">16879643</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Hong</surname><given-names>Y.</given-names></name><name><surname>Olczak</surname><given-names>A.</given-names></name><name><surname>Maier</surname><given-names>S. E.</given-names></name><name><surname>Maier</surname><given-names>R. J.</given-names></name></person-group> (<year>2006b</year>). <article-title>Dual Roles of <italic>Helicobacter pylori</italic> NapA in inducing and combating oxidative stress</article-title>. <source>Infect. Immun.</source>
<volume>74</volume>, <fpage>6839</fpage>&#x02013;<lpage>6846</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00991-06</pub-id><?supplied-pmid 17030577?><pub-id pub-id-type="pmid">17030577</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Maier</surname><given-names>R. J.</given-names></name></person-group> (<year>2004</year>). <article-title>An NADPH quinone reductase of <italic>Helicobacter pylori</italic> plays an important role in oxidative stress resistance and host colonization</article-title>. <source>Infect. Immun.</source>
<volume>72</volume>, <fpage>1391</fpage>&#x02013;<lpage>1396</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.72.3.1391-1396.2004</pub-id><?supplied-pmid 14977943?><pub-id pub-id-type="pmid">14977943</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Medicinal plant activity on <italic>Helicobacter pylori</italic> related diseases</article-title>. <source>World J. Gastroenterol.</source>
<volume>20</volume>, <fpage>10368</fpage>&#x02013;<lpage>10382</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v20.i30.10368</pub-id><?supplied-pmid 25132753?><pub-id pub-id-type="pmid">25132753</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wessler</surname><given-names>S.</given-names></name><name><surname>Krisch</surname><given-names>L. M.</given-names></name><name><surname>Elmer</surname><given-names>D. P.</given-names></name><name><surname>Aberger</surname><given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>From inflammation to gastric cancer-the importance of Hedgehog/GLI signaling in <italic>Helicobacter pylori</italic>-induced chronic inflammatory and neoplastic diseases</article-title>. <source>Cell Commun. Signal.</source>
<volume>15</volume>, <fpage>15</fpage>. <pub-id pub-id-type="doi">10.1186/s12964-017-0171-4</pub-id><?supplied-pmid 28427431?><pub-id pub-id-type="pmid">28427431</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Windle</surname><given-names>H. J.</given-names></name><name><surname>Fox</surname><given-names>A.</given-names></name><name><surname>N&#x000ed; Eidhin</surname><given-names>D.</given-names></name><name><surname>Kelleher</surname><given-names>D.</given-names></name></person-group> (<year>2000</year>). <article-title>The thioredoxin system of <italic>Helicobacter pylori</italic></article-title>. <source>J. Biol. Chem.</source>
<volume>275</volume>, <fpage>5081</fpage>&#x02013;<lpage>5089</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.275.7.5081</pub-id><?supplied-pmid 10671551?><pub-id pub-id-type="pmid">10671551</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanaka</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Sulforaphane enhances protection and repair of gastric mucosa against oxidative stress <italic>in vitro</italic>, and demonstrates anti-inflammatory effects on <italic>Helicobacter pylori</italic>-infected gastric mucosae in mice and human subjects</article-title>. <source>Curr. Pharm. Des.</source>
<volume>17</volume>, <fpage>1532</fpage>&#x02013;<lpage>1540</lpage>. <pub-id pub-id-type="doi">10.2174/138161211796196945</pub-id><?supplied-pmid 21548875?><pub-id pub-id-type="pmid">21548875</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Xie</surname><given-names>G.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production</article-title>. <source>Cell Death Dis.</source>
<volume>4</volume>:<fpage>e794</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2013.334</pub-id><?supplied-pmid 24030146?><pub-id pub-id-type="pmid">24030146</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>W.</given-names></name><name><surname>Pham</surname><given-names>T. T.</given-names></name><name><surname>Rogers</surname><given-names>A. B.</given-names></name><name><surname>Houghton</surname><given-names>J. M.</given-names></name><name><surname>Moss</surname><given-names>S. F.</given-names></name></person-group> (<year>2016</year>). <article-title>Native and bone marrow-derived cell mosaicism in gastric carcinoma in <italic>H. pylori</italic>-infected p27-deficient mice</article-title>. <source>Oncotarget</source>
<volume>7</volume>, <fpage>69136</fpage>&#x02013;<lpage>69148</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.12049</pub-id><?supplied-pmid 27655701?><pub-id pub-id-type="pmid">27655701</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Lin</surname><given-names>Z.</given-names></name><name><surname>Lin</surname><given-names>G.</given-names></name><name><surname>Lv</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Compound 13, an alpha1-selective small molecule activator of AMPK, inhibits <italic>Helicobacter pylori</italic>-induced oxidative stresses and gastric epithelial cell apoptosis</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>463</volume>, <fpage>510</fpage>&#x02013;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2015.05.059</pub-id><?supplied-pmid 26022128?><pub-id pub-id-type="pmid">26022128</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zitvogel</surname><given-names>L.</given-names></name><name><surname>Pietrocola</surname><given-names>F.</given-names></name><name><surname>Kroemer</surname><given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>Nutrition, inflammation and cancer</article-title>. <source>Nat. Immunol.</source>
<volume>18</volume>, <fpage>843</fpage>&#x02013;<lpage>850</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3754</pub-id><?supplied-pmid 28722707?><pub-id pub-id-type="pmid">28722707</pub-id></mixed-citation></ref></ref-list></back></article>